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1 Abstract 
The recently discovered SMC-hinge and MutL-homology domain (SMUDO) protein was found to 
be a potential interaction partner of the stress induced homeodomain-interacting protein kinase 
2 (HIPK2) which acts as a switching element in the DNA damage response. Upon severe DNA 
damage, HIPK2 induces apoptosis via p53-dependent as well as p53-independent pathways. 
SMUDO protein exhibits structural domains showing homology with the SMC and MutL protein 
families, both known for their involvement in DNA repair mechanisms.  
The aim of this thesis was to characterize the SMUDO protein and to investigate its putative 
connection to HIPK2 as well as its possible functions in the context of the DNA damage response.  
Early analysis by Northern blot, RT-PCR and Western blot revealed ubiquitous expression of 
SMUDO in human tissue samples as well as in diverse cell lines, suggesting functions that are not 
restricted to specific tissues. 
Various DNA damage pathways have been studied to find indications for a role of SMUDO, where 
the focus was on those in which HIPK2 participates. Several kinds of DNA damage, such as 
double or single strand breaks as well as pyrimidine dimers, were generated by Adriamycin 
treatment or UV, stimuli which are known to activate HIPK2. However, SMUDO levels showed no 
alterations under these conditions, and SMUDO knockdown had no effect on levels of HIPK2, p53 
phosphorylated at Ser46 or other DNA damage response transducers.  
Pulldown experiments concerning HIPK2-SMUDO interaction support in vitro binding of the 
proteins, whereas in vivo interaction could not be confirmed by co-immunoprecipitation or 
immunofluorescence so far. This is probably due to SMUDO association to an insoluble fraction 
inside the nucleus, presumably chromatin. By FRAP technique, it could be shown that the SMC-
hinge domain and the MutL domain of SMUDO influence the localization and mobility of the 
protein. The MutL domain seems to be responsible for a primarily nuclear localization of the 
protein and association with the insoluble nuclear fraction, while the SMC-hinge domain 
supports this association further limiting the mobility of SMUDO within the nucleus. Moreover, it 
could be demonstrated by co-immunoprecipitation that the SMC-hinge domain mediates 
SMUDO-SMUDO interaction.  
Summarized, a SMUDO-HIPK2 interaction in the context of the DNA damage response seems to 
be unlikely. However, functional cooperation of the proteins might take place within other 
cellular processes such as epigenetic regulation. 
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2 Zusammenfassung 
Das kürzlich entdeckte SMC-hinge and MutL domain (SMUDO) Protein wurde als potentieller 
Interaktionspartner der Stress-induzierten Homeodomain-interacting protein kinase 2 (HIPK2), 
welche eines der entscheidenden Elemente der DNS-Schadensantwort ist, identifiziert. Nach 
massiven DNS-Schäden induziert HIPK2 Apoptose über p53-abhängige sowie über p53-
unabhängige Signalwege. Das SMUDO-Protein besitzt strukturelle Domänen, welche Homologien 
zu den SMC- und MutL-Proteinfamilien, die beide für ihre Beteiligung an DNS-
Reparaturmechanismen bekannt sind, aufweisen. 
Ziel dieser Arbeit war die Charakterisierung des SMUDO-Proteins und die Untersuchung sowohl 
seiner potentiellen Verbindung zu HIPK2 als auch seiner mögliche Rolle in der DNS-
Schadensantwort. 
Frühe Analysen durch Northern Blot, RT-PCR und Western Blot  ergaben eine ubiquitäre 
Expression von SMUDO in humanen Gewebeproben sowie in diversen Zelllinien, was auf eine 
Funktion des Proteins hinweist, die nicht auf ein spezifisches Gewebe beschränkt ist. 
Verschiedene DNS-Schadenssignalwege wurden untersucht, um Indizien für eine Funktion von 
SMUDO zu finden, wobei der Fokus auf Signalwegen lag, an denen HIPK2 teilhat. 
Unterschiedliche Arten von DNS-Schäden, wie Einzel- oder Doppelstrangbrüche sowie 
Pyrimidindimere, bekannte HIPK2-aktivierende Stimuli, wurden durch Adriamycin-Behandlung 
oder UV-Strahlung generiert. Jedoch zeigten die SMUDO-Proteinlevels keine Veränderung unter 
diesen Bedingungen. Auch hatte eine starke Reduzierung des SMUDO-Levels keinen Effekt auf 
die Levels von HIPK2, an Serin46 phosphorylierten p53 oder anderen Signaltransduktions-
komponenten der DNS-Schadensantwort. 
Pulldown-Experimente die sich auf HIPK2-SMUDO-Interaktion beziehen, untermauern in vitro-
Bindung der Proteine, wohingegen in vivo-Interaktion bisher noch nicht durch  Ko-
Immunpräzipitation oder Immunfluoreszenzfärbung bestätigt werden konnte. Dies liegt 
vermutlich an der Assoziation von SMUDO mit einer unlöslichen Fraktion des Nukleus, wobei es 
sich wahrscheinlich um Chromatin handelt.  Durch FRAP-Techniken konnte gezeigt werden, dass 
die SMC-hinge- und MutL-Domänen von SMUDO die Lokalisation und Mobilität des Proteins 
beeinflussen. Die MutL-Domäne scheint für die primär nukleäre Lokalisation sowie für die 
Assoziation mit der unlösliche Fraktion verantwortlich zu sein, während die SMC-hinge-Domäne 
diese Assoziation unterstützt und damit die Mobilität von SMUDO innerhalb des Nukleus weiter 
einschränkt.  
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Des Weiteren konnte demonstriert werden, dass die SMC-hinge-Domäne SMUDO-SMUDO-
Interaktion vermittelt. 
Zusammengefasst ist eine SMUDO-HIPK2-Interaktion im Kontext der DNS-Schadensantwort 
unwahrscheinlich. Jedoch könnte eine funktionelle Kooperation der Proteine innerhalb anderer 
zellulärer Prozesse, wie der epigenetischen Regulation, stattfinden. 
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3 Introduction 
3.1 Cancer & DNA damage 
Research revealed cancer to be a disease whose development is a multistep process in 
which a cell acquires several capabilities that allow it to become a population of malignant 
cells. During this process intracellular changes affect several signaling pathways like growth 
factor signaling, control of angiogenesis and regulation of apoptosis. Every single acquired 
capability constitutes an advantage in growth and therefore drives the Darwinian selection 
of the concerned cells. Common basis of these alterations are genetic aberrations, thus poor 
DNA changes present the initial event in carcinogenesis (Hanahan&Weinberg, 2000; Negrini 
et al, 2010).  
DNA damage induced by environmental agents or produced spontaneously during (DNA) 
metabolism is a permanent threat for genome integrity. It has been estimated that up to 105 
spontaneous DNA lesions per day can emerge in a single cell (Hoeijmakers, 2009). This 
includes DNA breaks and oxidized DNA bases generated by reactive oxygen species (ROS), a 
byproduct of normal cellular metabolism, misincorporation of dNTPs during DNA 
replication, deamination of DNA bases and other base modifications. Additionally 
environmental DNA damage is caused by chemical and physical sources such as diverse 
(waste) products of the chemical industry, chemotherapeutic agents, ultraviolet light (UV) 
from the sunlight and ionizing radiation (IR) from medical X-ray administration or cosmic 
radiation. 
In healthy human cells complex enzymatic machinery continuously counteracts occurring 
DNA damage. This signal transduction pathway designated as DNA damage response (DDR) 
functions as a kinase cascade activated upon DNA damage but also in response to replicative 
stress (Gorgoulis et al, 2005; Kastan&Bartek, 2004). The DDR and its possible outcomes, 
DNA repair, cellular senescence and apoptosis, represent a biological barrier that reduces 
cellular transformation into a malignant state to an event of marginal probability (Bartkova 
et al, 2005). Of course, deficiency in components of the DDR itself can lead to accumulation 
of heritable mutations and therefore threatens genome maintenance. 
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Hence it could been shown that virtually all types of cancer exhibit dysfunctional key 
components of the DDR, which give a premalignant cell the means to acquire more 
capabilities and evolve into a malignant population (Hanahan&Weinberg, 2000). These 
proteins, for instance the ataxia telangiectasia mutated (ATM) protein or the transcription 
factor p53, are considered as tumor suppressors. 
 
3.2 The DNA damage response 
Once activated the DDR dictates the further cell fate dependent on the cellular context and 
the extent of damage (Bartek et al, 2007). Generally cells attempt to correct occurring 
mutations and to resume their natural life cycle. So they do upon mild DNA damage that 
induces cell cycle arrest to provide a window for cellular repair efforts. After severe DNA 
damage the repair machinery may be insufficient to master the plenty of injuries. In this 
case the DDR is able to drive a cell either into apoptosis, a controlled cell death, or 
senescence, a state in which further cell division is blocked but a cell is still allowed to fulfill 
its physiological function to some extent (Campisi&d'Adda di Fagagna, 2007; Ciccia&Elledge, 
2010). Both options eliminate the premalignant cell from the pool of proliferating cells and 
prevent propagation of compromised genetic information. A network of tightly regulated 
sensors, transducers and effectors governs the DDR and ensures an appropriate response to 
the extent of damage. 
The diversity of DNA lesions raised the need of adequate countermeasures and a set of 
distinct repair mechanisms has evolved from unicellular organisms to man to maintain 
genomic integrity and guarantee accurate transmission of genetic information across 
generations. In particular the human DNA damage repair machinery consists of at least five 
systems: Mismatch repair (MMR), base excision repair (BER), nucleotide excision repair 
(NER), nonhomologous end joining (NHEJ) and homologous recombination (HR) (David et 
al, 2007; Friedberg, 2001; Hoeijmakers, 2001; Jackson&Bartek, 2009). Among these, NHEJ is 
known to be one of the most error prone repair mechanisms, therefore its trigger, DNA 
double-strand breaks (DSBs), belongs to the most threatening types of DNA damage, which 
can be induced by physical exogenous agents like IR or endogenous agents such as ROS. 
DDR kinase cascade is primarily mediated by the phosphatidylinositol 3-kinase-related 
kinases ATM, ataxia telangiectasia and Rad3-related (ATR) protein and DNA-dependent 
protein kinase (DNA-PK). ATM and DNA-PK are primarily activated upon DSBs whereas 
activation of ATR is triggered by replication protein A (RPA) coated single-stranded DNA 
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(ssDNA) that is a result of replication fork stalling but also occurs during DSB repair. Once 
induced, the kinases phosphorylate mediator proteins, which amplify the DDR by recruiting 
ATM and ATR substrates (Zhou&Elledge, 2000). Effector proteins can either be directly 
phosphorylated by ATM/ATR or by downstream kinases such as the checkpoint kinases 1 
and 2 (CHK1, CHK2) or the homeodomain interacting kinase 2 (HIPK2) (Harper&Elledge, 
2007; Hofmann et al, 2002). 
Several sensors can detect DSBs, including the MRN-complex consisting of Mre11, Rad50 
and Nbs1, that binds to the site of damage and recruits and activates ATM (Ciccia&Elledge, 
2010). ATM then phosphorylates the histone H2A variant H2AX at serine 139 to form 
γH2AX, a binding platform for the mediator of checkpoint 1 (MDC1) and other repair factors. 
MDC1 and p53-binding protein1 (53BP1) facilitate the recruitment of additional MRN-ATM 
complexes which in turn boost the phosphorylation of H2AX. As a result of these positive 
feedback loop, γH2AX spreads up to 1-2 megabases around the DNA lesion and forms, 
together with other recruited proteins, so called γH2AX foci (van Attikum&Gasser, 2009). 
Moreover, ATM phosphorylates and activates the downstream kinase CHK2 in a MDC1 and 
53BP1 dependent manner (Buscemi et al, 2004). 
After getting activated, CHK2 diffuses in the nucleoplasm transmitting DDR signal 
throughout the nuclear space by phosphorylating its substrates such as cell-division cycle 
25 (CDC25) phosphatases causing rapid cell-cycle arrest by its inhibition (Mailand et al, 
2000). Phosphorylation of another target, transcription factor p53, leads to its stabilization 
and to increased transcription of p21, an inhibitor of cyclin-dependent kinases, and 
subsequently to stable cell-cycle arrest. Additional phosphorylation of p53 by downstream 
kinase HIPK2 stimulates p53 driven pro-apoptotic gene expression (Hofmann et al, 2002). 
When single stranded (ss)DNA is exposed, for instance upon replication fork stalling, RPA 
binds to it and a sensor complex made of ATR and the ATR-interacting protein (ATRIP) 
associates with ssDNA/RPA (Cortez et al, 2001). ATR activity is amplified by topoisomerase-
II-binding protein 1 (TOPBP1) and further boosted by the heterotrimeric 9-1-1 complex 
consisting of RAD9, RAD1 and HUS1 (Kumagai et al, 2006; Weiss et al, 2002). One of the 
main ATR targets is CHK1, which is also an inhibitor of CDC25. Overall it is estimated that 
ATR and ATM phosphorylate more than 700 substrates in response to DNA damage 
(Matsuoka et al, 2007). 
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3.3 HIPK2 
Homeodomain interacting protein kinase 2 (HIPK2) is the best known member of a family of 
conserved Ser/Thr directed kinases and has been implicated in a range of cellular processes, 
such as regulation of apoptosis or pathways involved in development or differentiation 
(Bitomsky&Hofmann, 2009; Calzado et al, 2007). Three of the four family members, HIPK1-
3, were originally identified as co-repressors of the homeodomain transcription factor NK3, 
and later on, the slightly more distant related HIPK4 was found due to sequence homology 
to the already known HIP-kinases (Arai et al, 2007; Kim et al, 1998). As a result of their high 
homology, the family members seem to be partially redundant in their functions. For 
instance, it could be shown that HIPK2 and HIPK1 singly deficient mice have no severe 
phenotype whereas HIPK1/HIKP2 double knockout mice die during embryogenesis (Isono 
et al, 2006). 
HIPK2 is activated in response to genotoxic stress or by morphogenic signals and a plenty of 
substrates phosphorylated by HIPK2 at preferential serine or threonine residues followed 
by proline (SP/TP motifs) has been identified. Transcriptions factors like CtBP, c-Myb and 
CBP/p300 belong to the group of HIPK2 targets (Aikawa et al, 2006; Kanei-Ishii et al, 2004; 
Zhang et al, 2003). The most prominent target is the transcription factor and tumor 
suppressor p53. Upon severe DNA damage caused by environmental sources like UV and IR 
or by chemotherapeutics such as doxorubicin (adriamycin), HIKP2 is stabilized and 
phosphorylates p53 at Ser46, driving pro-apoptotic gene expression (D'Orazi et al, 2002; 
Dauth et al, 2007; Gresko et al, 2006; Hofmann et al, 2002). In addition, HIPK2 can promote 
apoptosis also in p53 independent manners. This includes activation of pro-apoptotic c-Jun 
NH(2)-terminal kinase (JNK) by affecting the TGF-beta pathway or stimulation of 
proteasomal degradation of anti-apoptotic transcriptional co-repressor C-terminal binding 
protein (CtBP) (Hofmann et al, 2003; Zhang et al, 2003). 
In 2007 a study revealed HIPK2 to be a haploinsufficient tumor suppressor in the skin of a 
mice model probably acting by repressing cyclin D1 expression (Wei et al, 2007). The most 
recent support for the tumor suppressing function of HIPK2 is given by two publications, 
one shows that impaired HIPK2 expression in well-differentiated thyroid carcinomas 
(WDTCs) leads to overexpression of galectin-3 (Gal-3), an anti-apoptotic protein, and the 
second confirms the role of HIPK2 as haploinsufficient tumor suppressor, this time using a 
mouse lymphoma model (Lavra et al, 2011; Mao et al, 2011). Despite strong indications for a 
tumor suppressing function of HIPK2, there is still some discussion about this subject due to 
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controversial findings. On the one hand the pro-apoptotic function of HIPK2 trigged by DNA 
damage is known and its inactivation or down-regulation in several kinds of tumors has 
been demonstrated, on the other hand inactivation has been found only in a limited number 
of tumor types and moreover HIPK2 was shown to be overexpressed in some other cases 
(Al-Beiti&Lu, 2008; Bar et al, 2008; Deshmukh et al, 2008; Pierantoni et al, 2002; Pierantoni 
et al, 2007). 
As mentioned before, besides its role in apoptosis regulation HIPK2 is involved in processes 
concerning development and differentiation. To give two examples: It phosphorylates and 
transactivates Pax6, a transcription factor that is essential for the development of eyes and 
other sensory organs, and also AML1 and p300, both important for hematopoiesis (Kim et al, 
2006; Yoshida&Kitabayashi, 2008). 
During the last years indications were given that HIPK2 might be involved in epigenetic 
processes. For example, HIPK2 was shown to phosphorylate and downregulate the methyl-
binding transcription factor ZBTB4 which is known to repress p21 transcription (Weber et 
al, 2008; Yamada et al, 2009). Similar to this HIPK2 phosphorylates the methyl-CpG-binding 
protein 2 (MeCP2) promoting apoptosis induction in the brain (Bracaglia et al, 2009; 
Chahrour&Zoghbi, 2007). 
 
 
Figure 1: Schematic presentation of S/T protein kinase HIPK2. Functional domains and important residues are 
indicated, along with a selection of interaction partners. HID = homeoprotein interaction domain. SRS = speckle 
retension signal. AID = auto-inhibitory domain. D916, D977 = caspase cleavage sites. Yellow bars = nuclear 
localization signals (NLS). Illustration adapted and modified from Sombroek&Hofmann, 2009. 
 
The overall protein structure of HIPK2 is characterized by an N-terminal kinase domain, a 
centrally located homeodomain interaction domain and an auto-inhibitory domain (AID) at 
the C-terminus, that plays a central role in regulation of HIPK2 activity since it is cleaved at 
Asp916 and Asp977 by caspase 6 upon DNA damage which leads to hyperactivation of 
kinase domain activity and thereby to amplification of the 53 response (Gresko et al, 2006). 
Alternatively, the AID can be masked by proteins such as Axin consequently preventing 
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auto-inhibition (Rui et al, 2004). Between the auto-inhibitory domain and the homeodomain 
interacting domain, a speckle-retention signal (SRS) is situated. Three nuclear localization 
signals (NLS) contained in the amino acid sequence of HIPK2 ensure a predominantly 
nuclear localization, while the SRS further promotes localization to nuclear bodies (NBs) 
(Kim et al, 1998). These NBs co-localize in part with domains of the epigenetic polycomb 
group (PcG) transcription repressors, a fact that supports the possibility of HIPK2 
involvement in transcriptional regulation on epigenetic level (Roscic et al, 2006). HIPK2 can 
be covalently modified by attachment of small ubiquitin-like modifier (SUMO)-1 to lysine 
residue 25. Sumoylation leads to enhanced JNK activation by HIPK2 and further seems to 
augment its co-repressor function (Gresko et al, 2005; Hofmann et al, 2005; Roscic et al, 
2006). 
In unstressed cells HIPK2 has a high turnover due to constant degradation via the 
proteasomal system. Several ubiquitin E3 ligases, Siah1, Siah2, HDM2 and WSB-1 have been 
demonstrated to stimulate HIKP2 degradation (Calzado et al, 2009; Choi et al, 2008; Rinaldo 
et al, 2007a; Winter et al, 2008). Additional negative regulation is accomplished by proteins 
keeping away HIPK2 from potential targets. This is the case for the high-mobility group A1 
(HMGA1) protein which binds HIPK2 and re-localizes the protein into the cytoplasm 
preventing p53 phosphorylation (Pierantoni et al, 2007). 
 
3.4 The SMC protein family 
The members of the structural maintenance of chromosomes (SMC) protein family 
constitute the core of multi-protein complexes that use energy from ATP hydrolysis to 
regulate the structural and functional organization of chromosomes. SMC proteins were 
initially identified in genetic screens in Saccharomyces cervisiae and it was shown that SMC 
defects destabilize chromosome segregation (Haering&Nasmyth, 2003). Over the following 
years many SMC proteins have been identified and studied in bacteria, yeast, nematodes and 
higher eukaryotes. At first two SMC complexes, cohesin and condensin, and their 
contribution in chromosome restructuring during mitosis were the matter of research 
(Hirano&Hirano, 2002; Matoba et al, 2005; Strunnikov et al, 1995). But since their initial 
description, a third complex, SMC5-SMC6, was discovered and SMC proteins have been 
implicated in a growing number of chromosomal activities such as recombination, DNA 
repair and epigenetic silencing of gene expression (Chuang et al, 1994; Haering et al, 2002; 
Lee&O'Connell, 2006; Losada&Hirano, 2005; Taylor et al, 2001). 
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Mammalian SMC proteins range in size from 110 to 170 kDa and they exhibit five common 
structural domains: A central hinge domain, two nucleotide-binding domains at the termini, 
and two coiled-coil regions separating the other domains. During maturation the proteins 
fold back through antiparallel coiled-coil interactions forming a ATPase head domain at one 
end and a hinge domain at the other (Melby et al, 1998). SMC hinge domains mediate the 
formation of V-shaped (condensin) or ring-like (cohesin, SMC5-SMC6) SMC heterodimers 
which act as the core component of multi-protein complexes, each containing several 
regulatory non-SMC subunits that bind to the ATP head domains thereby able to close the 
arms of the dimers (Hirano&Hirano, 2002). In particular SMC1-SMC2 act as the core of 
cohesin that is essential for sister-chromatid cohesion (Haering&Nasmyth, 2003) and SMC2-
SMC4 functions as the core unit of condensin which is important for chromosome assembly 
and segregation (Hirano, 2005). SMC5-SMC6 heterodimers constitute the core of a yet 
unnamed complex (so far called SMC5-SMC6 complex) that has been shown to be involved 
in DNA repair and checkpoint responses (Lehmann, 2005). 
Besides their functions in chromosomal metabolism, checkpoint signaling and DNA repair 
which had been in the focus of SMC protein studies over the decades, involvement in 
epigenetic mechanisms was indicated by several studies. For instance, it was shown that a 
complex closely related to condensin acts as a critical regulator of dosage compensation in C. 
elegans (Chuang et al, 1994; Jans et al, 2009). Furthermore, interactions of condensin 
subfractions with epigenetic factors like DNA methyltransferases were revealed (Geiman et 
al, 2004). 
Two nucleotide-binding motifs, called Walker and Walker B motifs, are located at the N-
terminus and C-terminus of SMC proteins, respectively (Fig. 2, panel B). Additionally a 
conserved C motif, that is also found in the family of ATP-binding cassette (ABC) ATPases, is 
contained in the C-terminus. ATP binding to the pockets made by the Walker motifs of one 
SMC subunit stimulates head-head engagement in a way that the bound ATP makes contact 
with the C motif of the second SMC subunit forming a nucleotide-sandwich dimer. 
Subsequent ATP hydrolysis triggers disengagement of the head domains and release of ADP 
completes the SMC-ATPase cycle (Lammens et al, 2004), which is therefore thought to play a 
critical role in SMC-DNA interaction. 
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Figure 2: Architecture of SMC dimers and potential action of cohesin. (A) Sketch of the basic architecture of SMC 
dimers, the core component of SMC protein complexes. The SMC subunits fold back by antiparallel coiled-coil 
interaction to form a flexible arm, an ATP-binding head at one end and a hinge domain at the other. Hinge domains 
mediate dimerization and give rise to a V-shaped structure. (B) The ring model in which cohesin embraces two sister 
chromatids. Yellow dots indicate bound ATP. Images adapted and modified from Hirano et al., 2006. (C) The structure 
of the cohesin complex includes the non SMC subunits sister chromatid cohesion protein 1 and 3 (Scc1, Scc3). 
Containing a zinc hook instead of a hinge domain the SMC related Rad50 protein provides the core of the MRN 
complex which detects DNA damage and activates DNA damage checkpoint via ATM. 
 
Hinge and head domains of SMC proteins are separated by coiled-coil domains that are 
responsible for stable backfolding of the maturing protein. They also constitute a prominent 
feature of the SMC complexes: Their length. Each coiled-coil arm is approximately 50 nm 
long, a distance that is equivalent to that of 150 bp of double-stranded DNA. Considering the 
possibilities of closing the SMC complex structure by hinge-hinge interaction, head-head 
engagement triggered by ATP binding or head-head contact mediated by non-SMC subunits, 
respectively, an elongated ring structure with a noticeable circumference comes up. Due to 
this architecture, it has been early supposed that SMC complexes accomplish their functions 
by encircling one or more DNA strands (Haering et al, 2002). 
In contrast to the head-head engagement that is controlled by ATP binding and hydrolysis, 
the hinge-hinge interaction was shown to be very strong and independent of ATP. 
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Furthermore there is no hint so far that any cations are required for hinge-mediated SMC 
dimerization, as it is the case in the zinc-hook domain of the SMC related Rad50 protein 
(Hopfner et al, 2002). Studies of BsSMC, a SMC homodimer in Bacillus subtilis, and 
mammalian SMC1 and SMC3 showed that a couple of conserved glycine residues are crucial 
for a stable hinge-hinge interaction of these proteins (Chiu et al, 2004; Hirano et al, 2001). 
Over the years it has been revealed that the SMC hinge domain is not only a dimerization 
domain, but also a vital factor of the dynamic interaction between SMC proteins and DNA 
(Hirano&Hirano, 2002).  
BsSMC has two positively charged basic patches (BP1 and BP2) made up of lysine residues 
located near the glycine dimerization interface in the hinge domains. It has been shown that 
BP2 is necessary for initial DNA binding. Binding then stimulates ATP hydrolysis and 
disengagement of the head domains which leads to conformational change in the hinge 
domains allowing BP1 to go into a more stable attachment to the DNA. As a result the arms 
of the complex encompass the DNA strand and subsequent ATP binding further stabilizes 
SMC-DNA interaction by causing new head-head engagement and enclosing of DNA strands 
(Hirano&Hirano, 2006). 
Their structure allows the SMC complexes to undergo intermolecular interactions. Electron 
microscopy studies confirmed open and closed V-shaped and ring-like structures, but also 
revealed rosette-like configurations in which 4-8 SMC dimers bind to each other through 
their head domains (Matoba et al, 2005; Melby et al, 1998). Whether these structures are 
functional or only artifacts is still unclear, but they display the various potential 
intermolecular SMC complex interactions. Thus further hypothetical formations are for 
instance a filament-like arrangement that consists of opened SMC heterodimers connected 
via the head domains or double rings composed of two dimers, again linked by the head 
domains. Besides such types of conformations, which would likely require ATP, other 
formations, independent of ATP but depending on interactions of coiled-coil regions, might 
be possible (Hirano, 2006).  
In mammalian cells existing DSBs are either repaired by NHEJ or by HR, where HR is the 
considerably more reliable mechanism since homologous regions of the sister chromatids, 
related sequences in the genome or homologous chromosomes are used as template to 
repair affected DNA. Spatial proximity of homologous regions is a requirement for this 
process, thus HR is favored during late S and G2 phase, when two sister chromatids are 
available and close to each other. First indications for a role of cohesin in DNA repair were 
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given by studies which showed that the absence of cohesin leads to impaired DSB repair in 
yeast and vertebrate cells (Sjogren&Nasmyth, 2001; Sonoda et al, 2001). Furthermore, it 
was show that after laser-induced DNA damage cohesin accumulates at the site of damage in 
mammalian cells (Kim et al, 2002). In yeast cohesin recruitment to DSBs depends on H2AX 
phosphorylation by the damage checkpoint kinases Mec1 and Tel1, orthologs of mammalian 
ATM and ATR, respectively (Unal et al, 2004). At least in mammalian cells ATM also directly 
phosphorylates SMC1 and this protein modification of cohesin seems to be important for its 
function in DNA repair, but not its role in cohesion (Kim et al, 2002; Kitagawa et al, 2004). 
Cohesin primary contribution to DSB repair is probably the establishment of a new link 
between the injured chromatid and its intact sister chromatid to allow HR (Strom et al, 
2004). 
While the physiological function of SMC5-SMC6 is not fully clarified yet, many studies have 
implicated an involvement of this third SMC complex in DNA damage repair. As early as the 
gene encoding for SMC6 was described for the first time, the connection to DNA damage 
response was made since the gene was found in screen for radiosensitive mutants in 
S.pombe (Lehmann et al, 1995). Like cohesin, SMC5-SMC6 accumulates at DSB sites and 
promotes sister chromatid recombination and observations suggest a model in which the 
complex actually recruits cohesin to the breaks sites (De Piccoli et al, 2006; Potts et al, 
2006). Moreover, a role of SMC5-SMC6 in maintaining G2 arrest is likely, because it was 
demonstrated that S.pombe smc6 mutant cells are able to establish G2 checkpoint after IR, 
but they escape arrest before DNA repair is completed and subsequent unrepaired DNA 
cumulates until lethal levels are reached and cells die (Harvey et al, 2004; Lehmann, 2005). 
 
3.5 MutL proteins and their functions 
Correction of mismatched and unmatched bases emerging from imperfect DNA replication is 
carried out by mismatch repair (MMR). The system has been recognized as critical for 
genomic stability, humans and mice inheriting defects in MMR components are susceptible 
to tumor formation. For instance, over 90% of cases of hereditary nonpolyposis colorectal 
cancer (HNPCC) show malfunction in MMR (Peltomaki, 2005). MMR is conserved from 
bacteria to men and has been intensively studied in E.coli, but also in yeast and human (Iyer 
et al, 2006). 
Since the correction of mismatched or unmatched base pairs requires the proper template, 
nucleotide removal has to be specific to the newly synthesized DNA strand. In E.coli 
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discrimination depends on delayed methylation of the daughter strand while in eukaryotes 
the repair presumably starts from strand breaks such the 3’ or 5’ ends of Okazaki fragments 
in the lagging strand, or the 3’ end in the leading strand (Lacks et al, 1982; Yang, 2007). 
The MMR process in E.coli can be summarized as followed: MutS (mutator S) protein 
recognizes Nucleotides which fail to make a Watson-Crick pair in the DNA duplex and binds 
to the site of concern. MutL (mutator L) protein is recruited to the MutS-mismatch complex 
and couples the error recognition to incision of the new daughter stand, subsequent 
nucleotide removal and de novo strand synthesis. For incision MutL recruits MutH (mutator 
H) and, together with MutS, it activates the endonuclease which nicks the unmethylated 
strand of hemimethylated GATC sequences. Then UvrD helicase displaces the error-
containing strand segment and the gap is filled in by DNA Pol III and finally sealed by DNA 
ligase. The first two steps are again MutL mediated by direct interaction with UvrD as well 
as with DNA Pol III  (Polosina&Cupples, 2010a). In human MMR the MutL and MutS 
orthologs MutL-α and MutS-α and –β, respectively, act in concert with the exonuclease ExoI, 
since there is no MutH homolog existing, and other downstream repair-associated proteins 
many of which have not been identified for far. However, many of the known factors interact 
with MutL-α including ExoI, PCNA, RCF and Polη (Li, 2008). Because of its numerous known 
interactions and regulatory control of MMR proteins MutL is often designated to be the 
coordinator of the MMR pathway. 
For almost a decade after its first isolation and characterization in 1989 the MutL protein 
was thought to have no enzymatic activity. Because its activities can be only measured 
indirectly by its impact on interaction partners, all efforts to uncover simple biochemical 
activities of the protein have been unsuccessful until ATP binding capacity and a weak 
ATPase activity could be demonstrated simultaneously to determination of its crystal 
structure (Ban&Yang, 1998; Grilley et al, 1989). 
E.coli MutL functions as a homodimer of two MutL monomers whereas the human MutL-α is 
a heterodimer consisting of two paralogous proteins, MLH1 and PMS2. Stable dimers are 
formed by the C-terminal domain of the MutL monomers in E.coli and human, which is 
separated from the conserved N-terminal domain by a random coil (~90 AA in E.coli, ~300 
AA in human). N-terminal domains as well as C-terminal domains have been demonstrated 
to interact directly with DNA. In addition, N-terminal ATPase domains of MutL dimers can 
bind and hydrolyze ATP causing conformational alterations of the protein. While no ATP 
bound (apo-state), the N-terminal domains make no contact with each other. Following ATP 
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binding the N-terminal domains dimerize and the overall structure of the dimer adopt a 
more compact form (condensed state). ATP hydrolysis brings the dimer back into the less 
condensed state and subsequent ADP release causes dissociation of the N-terminal domains 
(Yang, 2000). Although the direct mechanistic and biochemical impact of the MutL ATPase 
cycle is still not fully understood, its importance is revealed by MutL mutants deficient in 
ATP binding and/or hydrolysis that are defective in MMR (Spampinato&Modrich, 2000). 
Besides their functions in MMR the MutL proteins have been shown to participate in several 
other DNA repair pathways such as very short patch repair (VSP) in E.coli, base excision 
repair (BER) and nucleotide excision repair (NER), and also in non-DNA repair pathways 
like cell-cycle signaling where MutL orthologs seem to initiate cell-cycle delay and  further 
apoptosis via ATR in a manner independent of MMR capacities (Cannavo et al, 2007; Cejka et 
al, 2003; Polosina&Cupples, 2010a). Growing evidence of MutL protein family involvement 
in a number of different pathways definitely show that MMR is not their only function and 
give rise to the idea that MMR may not even be their primary function but rather one 
component of their assigned tasks. 
 
3.6 SMUDO homologs 
To date, only two studies exist which deal with SMUDO-like proteins in particular. In 2008 a 
study was published that described a previously uncharacterized mouse gene whose 
product is an ortholog to the SMUDO protein, the subject of this thesis (Blewitt et al, 2008). 
Some years before the same group had performed an N-ethyl-N-nitrosourea (ENU) 
mutagenesis screen in mice to identify genes that are involved in epigenetic reprogramming 
(Blewitt et al, 2005). Several mutant phenotypes named MommeD1-6 (modifier of murine 
metastable epiallels) were produced and examined. The MommeD1phenotype showed a 
semidominant effect on transgene variegation, homozygous female-specific mid-gestation 
lethality and hypomethylation of the X-linked gene Hprt1 indicating a defect in X 
inactivation, a mechanism important for dosage compensation in mammalian female cells 
(Ng et al, 2007). 
The MommeD1 mutation was mapped to a gene which is located on mouse chromosome 17 
and exhibits a stop codon in exon 23 of 48 in total. Due to its homology to genes encoding for 
SMC proteins the gene was named SmcHD1 (structural maintenance of chromosomes hinge 
domain containing 1). Blewitt et al. characterized the SmcHD1 gene and its product using a 
mouse model carrying an SmcHD1 allele terminated by a gene trap, which featured the same 
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characteristics as the MommeD1 phenotype, thus confirming that the mutation in the 
SmcHD1gene is indeed causative of the MommeD1 phenotype (Blewitt et al, 2008). 
Several experiments concerning transcriptional activation of an X-linked transgene 
suggested that there is a defect in embryos undergoing random X inactivation and also in 
extraembryonic lineages undergoing imprinted X inactivation, such as placental tissue. 
SmcHD1MommeD1/MommeD1 females died during embryogenesis and a decrease in size of 
trophoblast giant cells, which support the embryo during development, was found.  
RNA fluorescent in situ hybridization (FISH) was used to verify regular expression of Xist 
transcript expression, the only event that is known to be essential for initiation of X 
inactivation. Localization of Eed, a core component of the polycomb repressive complex 2 
(PRC2) which targets genomic regions to be silenced during X inactivation by modifications 
like histone methylation, appeared normal. Furthermore, association of histone H3 
trimethylated on lysine 27 (H3K27me3), a marker for X inactivation, also seemed to be 
unaffected. These results indicated a normal initiation of X inactivation in homozygous 
mutant mice. 
Analysis of DNA methylation of 16 CpG islands subject to X inactivation at stage E10.5 
revealed hypomethylation in all cases in homozygous female compared to control animals, 
but no general hypomethylation was detected in chromosomal areas independent of X 
inactivation. Some of the genes tested were found to be up regulated. Additionally co-
localization of SmcHD1 and H3K27me3 marks could be shown in SmcHD1+/+ females. 
Together the results demonstrated a specific requirement for SmcHD1 in methylation of 
CpG islands during X inactivation, which is a prerequisite of gene silencing and maintenance 
of X inactivation. 
At the same time Kanno et al. presented a study concerning a protein which is involve RNA-
directed DNA methylation (RdDM) in Arabidobsis thaliana and features a characteristic SMC-
hinge domain (Kanno et al, 2008). It had been shown before that in plants small RNAs 
directed against enhancer regions can trigger de novo cytosine methylation and subsequent 
transcriptional silencing (Huettel et al, 2007). In their study Kanno et al. searched for 
components of the RdDM system by targeting an enhancer upstream a GFP reporter gene. 
They noticed DNA methylation not only at the promoter side as expected, but also beyond 
that, and the process included secondary siRNAs. 
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In a screen for mutants defective for enhancer methylation and further investigations they 
identified a gene (DMS3; DEFECTIVE IN MERISTEM SILENCING 3) whose product exhibits a 
domain similar to the hinge domain region of SMC proteins. According to their findings 
Kanno et al. proposed that the protein could potentially link nucleic acids during RNAi-
mediated epigenetic modifications in a way that it holds together siRNA and target DNA. 
Considering both studies, one function of SMUDO protein might be participation in DNA 
methylation or epigenetic regulation in general. Nevertheless, its characteristic structure 
and other hints presented in this thesis suggested a potential role in DNA damage response. 
 
3.7 Task of this thesis 
SMUDO is a recently discovered and sparsely characterized protein. Its structural features 
link it to the SMC and MutL protein families which are involved in several DNA repair 
mechanisms such as mismatch repair and homologous recombination (Losada&Hirano, 
2005; Polosina&Cupples, 2010b). Furthermore, experimental evidence indicated a function 
in a pathway that includes HIPK2 (see results, sections 5.1 and 5.3), a serine/threonine 
directed kinase activated upon genotoxic stress (Sombroek&Hofmann, 2009).  
The aims of this thesis were to characterize fundamentally SMUDO protein and to search for 
indications for its functions, with focus on DNA damage response. 
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4 Materials and Methods 
4.1 General 
All commercially available chemicals were of analytic grade and used without further 
purification. If not otherwise stated standard reagents and solvents were purchased from 
Gerbu (Gaiberg, Germany), Sigma Aldrich (St. Louis, USA), Merck (Darmstadt, Germany), 
Roth (Karlsruhe, Germany), Biozol (Eching, Germany), AppliChem (Darmstadt, Germany) 
and Roche Diagnostics (Mannheim, Germany). 
The cell culture media and solutions were obtained from Invitrogen (Carlsbad, USA) and 
PAA Laboratories (Pasching, Austria). Further material is listed in section 4.8. 
 
4.2 Methods in microbiology 
4.2.1Transformation of chemical competent cells 
For transformation of chemically competent bacteria, Escherichia coli DH5-α, TOP10, BL21 
and SCS110 host strains from Invitrogen were used. For 50 µl of cell suspension were 
thawed on ice and mixed with 0.1-1.0 µg plasmid DNA or following ligation reactions with 
the complete aliquot. Suspensions of all bacteria strains except of SCS110 were incubated on 
ice for 5 min and head-shocked for 45 sec at 42°C. Aliquots were chilled on ice and diluted in 
1 ml 1xLB medium. Escherichia coli SCS110 cell were mixed with DNA and diluted with H2O 
to a volume of 80 µl. 20 µl KCM buffer was added and the suspension incubated on ice for 20 
min and thereafter on RT for 10 min before it was diluted in 1 ml 1xLB medium.  
Afterwards, all cell suspensions were incubated at 37°C for 1 h with moderate agitation. 
Aliquots were spread onto pre-warmed LB agar-plates containing kanamycin, ampicillin or 
spectinomycin as selection marker. Plates were incubated o/n at 37°C. 
 
4.2.2 Preparation of bacterial cultures 
For plasmid preparation or production of recombinant fusion proteins either 5 or 300 ml 
1xLB medium containing the appropriate selection marker were inoculated with a single 
clone and incubated o/n at 37°C and 180 rpm. For storage, 0.5 ml suspension of transformed 
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bacteria were mixed with 0.5 ml 60% (v/v) clycerol in a cryoconservation vial and 
transferred to a -80°C freezer. 
 
4.2.3 Screening of recombinants for fusion protein expression 
For expression of recombinant protein in E.coli in BL21, glutathione-S-transferase (GST) 
fusion constructs were established and proteins were purified by affinity chromatography 
using glutathione-sepharose. Expression was under control of the lac promoter and 
therefore induced by isopropyl- -D-thiogalactopyranoside (IPTG). To screen for fusion 
protein expression, 5 ml o/n cultures were prepared. Two times 500 µl of each cell 
suspension were diluted in 500 µl 1xLB medium supplemented with ampicillin and 
incubated o/n at 37°C and 180 rpm. 4 h prior harvesting, one culture of each clone was 
induced with 1 mM IPTG. Cultures were then centrifuged for 5 min at 5,000 rpm (Pico 17, 
Thermo Fischer Scientific) and resuspended in 200 µl SDS sample buffer. After heating at 
95°C for 5 min, samples were loaded onto a SDS-polyacrylamide gel and protein expression 
was analyzed by Coomassie blue staining and comparison of induced and non-induced 
cultures. 
 
4.2.4 Production of recombinant fusion proteins 
For production of GST or polyhistidine fusion proteins, 100 ml o/n cultures of transformed 
E.coli BL21 were used to inoculate 400 ml pre-warmed 1 x LB medium supplemented with 
the appropriate antibiotic. Cultures were incubated at 37°C for 1 hour before IPTG was 
added to a final concentration of 0.1 to 1 mM. Cells were harvested after incubation at 30°C 
for 4 to 12 hours by centrifugation at 5,000 rpm and 4°C for 10 min, pellets were stored o/n 
at 80°C or directly used for purification as described later on (section 4.7.8).  
 
4.3 Methods in cell biology 
4.3.1 Cell culture 
Work with mammalian cell was carried out under sterile conditions in appropriated flow 
hoods. 
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All used immortalized cell lines were obtained from ATCC (Manassa, USA) whereas all 
primary cell lines were received from the Coriell Institute repository (Camden, USA). 
Immortalized cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with heat-inactivated 10 % FCS (vol/vol),  2 mM L-glutamine, 50 U/ml 
penicillin/streptomycin, 1 mM sodium pyruvate and 10 mM Hepes at 37°C in a humidified 
atmosphere containing 5 % CO2. Medium for primary cells was additionally supplemented 
with non-essential amino acids (NEAA) and with 15 % FCS instead of 10 %. Every second to 
third day adherent cells were subcultered when they had reached confluency of 80-90 % on 
10 cm cell culture dishes. Growth medium was removed and cell layers washed with PBS 
before 2 ml of 0.25 % Trypsin-EDTA solution were added to detach cells. After short 
incubation growth medium was added and cell suspension collected by pipetting. Aliquots of 
desired size were transferred to new culture dishes. 
 
4.3.2 Cryoconservation 
For conservation cells were trypsinized when had reached 80-90 % confluency, resuspend 
and centrifuged at 1200 rpm and RT for 5 min (Varifuge RF, Heraeus Sepatech). Then cells 
were resuspended in supplemented growth medium containing 10 % DMSO and transferred 
into cryovials, which were cooled down on ice for a couple of minutes before stored at -80°C 
for 2-5 days. Finally the vials were transferred into a liquid nitrogen storage tank. Contrary 
the thawing of cryo-stored cells was carried out quickly. The vials were warmed at 37°C and 
cell suspension centrifuged at 1200 rpm and RT for 5 min. Cells were resuspended in pre 
warmed growth medium and plated onto cell culture dishes. After one day the medium was 
replaced by new. 
 
4.3.3 Transient transfection of eukaryotic cells 
Calcium phosphate transfection 
Calcium phosphate transfection was used for over expression experiments and as well as for 
production of lentivirus in 293T cells. One day prior transfection 2.5-3 x 106 cells were 
seeded onto 10 cm culture dishes. For transfection plasmid DNA was diluted in H2O to an 
overall volume of 450 µl, 500 µl 2 x HBS buffer and thereafter 50 µl 2.5 M CaCl2 were added. 
Aliquots were mixed vigorously and incubated for 5 min at RT. The Calciumphosphate-DNA-
precipitates were mixed again and put on cultured cell in a dropwise manner. Cells were 
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harvested 12-48 h after transfection. For production of lentivirus cells were washed with 
PBS 4 h after transfection and growth medium was renewed. Virus containing supernatant 
was harvested 36-48 h after transfection. 
 
Polyethylenimine transfection 
Another method used to transfect 293T cells is polyethylenimine (PEI) transfection. Cells 
were transfected on 10 cm dishes at 80-90 % confluence and PEI was used at ratio of 3 µl 
per µg plasmid DNA. For transfection PEI was diluted 1 ml Optimem (Invitrogen), plasmid 
DNA was added and aliquots were mixed vigorously. After incubation for 15 min at RT 
aliquots were given to cells by pipetting. Cells were harvested 12-48 h after transfection. 
 
FuGENE6 transfection 
To transfect U2OS cells for fluorescence experiments FuGENE6 (Roche) reagent was used. 
Cover slips had been placed in 24-well plates and cells were seeded on it. Cells were 
transfected when confluence of about 80 % was reached. FuGENE6 reagent was diluted with 
Optimem and aliquots were mixed by vortexing for 1 sec. Afterwards plasmid DNA was 
added and aliquots were mixed again prior incubation for 15-30 min. A ratio of 3 µl 
FuGENE6 to 1 µg DNA was used and the total volume of the transfection complex was 100 µl 
per 24-well. 24-wells were pre-filled with 1 ml of growth medium and transfection complex 
was added after incubation. About 24 hours after transfection cells were used for 
fluorescence experiments. For live cell imaging live cell chambers were used instead of 24-
well plates. 
  
HiPerFect siRNA transfection 
HiPerFect reagent (Qiagen) was used for transient siRNA transfect of mammalian cells. 6-
well were used as containers for this approach. Per 6-well a number of 2 x 105 of previously 
trypsinized cells was diluted in 1.8 ml growth medium. 100 µl Optimem were supplemented 
with 12 µl HiPerFect and 10 µl 20 µM siRNA, mixed and incubated for 5 min at RT. 
Subsequently aliquots were mixed with the prepared cell suspension and seeded onto the 6-
wells. The final siRNA concentration was 100 nM. Cells were harvested after 24 h to 48 h. 
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4.3.4 Lentiviral transduction of eukaryotic cell 
For production of lentiviral vectors 293T cells (10 cm dish) were transfected with 20µ a pG-
lenti vector which is based on the murine leukemia virus (MLV) and carries the transgene of 
interest and a GFP-reporter gene. Additional vectors encoding several packaging proteins 
and support factors were co-transfected along with the pG-lenti vector. In detail this were 5 
µg of pRSVrev vector, 5 µg pVSVg vector and 10 µg of pMDLg vector. 4 h after transfection 
growth medium was renewed. Transfection efficiency was checked under a fluorescence 
microscope. Virus containing medium was collected 48 h after transfection, centrifuged at 
1.200 rpm for 5 min and supernatant filtered using a PVDF-membrane filter with a diameter 
of 0.45 µm. Target cells were seeded on 6-wells and used for transduction at confluence of 
60-80 %. For this purpose growth medium was removed from 6-wells and replaced by 2 ml 
of virus containing medium supplemented with polybrene (final concentration: 8 µg per ml). 
Virus was spun down onto cells at 2.000 rpm and RT for 90 min. After 4 h cells could be 
subcultured to favored volumes and transduction efficiency was checked using a 
fluorescence microscope. 
 
4.3.5 Treatment of eukaryotic cells 
UV-irradiation 
To damage cells by UV-irradiation medium was removed and opened culture dishes were 
placed into a UV Stratalinker 1800. Disired UVC dosages were applied and new growth 
medium was quickly given to cells. Dependent on the experinent cell were harvested 5 min 
to 48 h after UV-irradiation. 
 
Doxorubicin (Adriamycin) treatment 
The chemotherapeutic drug Doxorubicin (a.k.a. Adriamycin) was used to induce DNA 
double-strand breaks. To do this growth medium was supplemented with Adriamycin at 
concentrations from 4-10 µM. 
 
Fluorouracil treatment 
Fluorouracil (5-FU) was used to induce G/T mismatch repair.  The drug was added to 
growth medium to final concentration of 5 to 55 µM. After 14 h of incubation medium was 
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renewed and cells were incubated under growth conditions to reach confluence appropriate 
to perform colony formation assays. 
 
4.3.6 Colony Formation Assay 
To assay cells viability upon various treatments colony formation assays were made. At first 
a defined number of cells were seeded on several cell culture dishes of the same size. When 
adherent cells were treated in an experimental dependent manner, they were subsequently 
incubated under growth conditions until requested confluence was reached. Medium was 
removed and cells were fixed and stained at the same time by incubation with crystal violet 
solution for 10 min. Cells were washed with water for three times to remove remaining 
staining solution before were air dried. Number of cells was dependent of the cell type and 
the size of the culture dishes used for the concerning experiment. Typically, 106 HCT116 
cells were seeded on one well of a 6-well plate. 
 
4.4 Methods in molecular biology 
4.4.1 Plasmid preparation 
For isolation of plasmid DNA at analytical scale, 2 ml of o/n cultures were centrifuged at 
4,500 rpm, RT for 5 min (Pico 17, Thermo Fischer Scientific). Afterwards plasmid DNA was 
isolate by using the QIAprep Spin Miniprep kit, which is based on the methods of alkaline 
lysis and anion-exchange chromatography, according to the manufacturer’s protocol. For 
isolation of larger amounts of plasmid DNA, 300 ml of o/n culture were centrifuged at 5,000 
rpm and 4°C for 10 min (GS3, Sorvall Instruments). Plasmid DNA was isolated by using 
Qiagen Plasmid Maxi Kit. Quantity and purity of isolated DNA were determinate by using a 
micro-volume spectrophotometer from NanoDrop Technologies to measure absorption at 
260 nm and 280 nm.  
 
4.4.2 Agarose gel electrophoresis 
For analysis or preparation DNA fragments were separated in 0,7-1,5 % (w/v, in 1 x TAE 
buffer) agarose  gels containing ethidium bromoide (EtBr) at 5-10 V/cm. DNA fragments 
were visualized via simulating fluorescence of intercalated EtBr by UV radiation.  
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4.4.3 DNA digestion and molecular cloning 
DNA digestion 
For a typical digestion reaction of DNA 0.2-2 µg of Plasmid DNA were incubated with 1-10 
units (U) of the appropriate restriction enzyme under producer defined conditions. The total 
volume was 20 µl and incubation time 10-60 min. Resulting DNA fragments were separated 
by agarose gel electrophoresis (see 4.4.2) and required fragments cut out of the gel. DNA 
was purified from agarose gel by means of QIAquick Extraction Kit (Qiagen). 
 
 Dephosphorylation 
To remove 5´-phosphates of DNA, 0.2-1 µg DNA was incubated with 1 U of calf intestine 
phosphatase (CIP) in appropriate buffer (total volume: 30µl) for 30 min at 37°C. CIP was 
inactivated by heating aliquots at 74°C for 10 min. 
 
Ligation 
To ligate DNA fragments into a plasmid vector, 50-500 ng of the digested and 
dephosphorylated vector were incubated with the 3 to 5-fold molar amount of insert DNA 
fragment and 1 U T4-DNA ligase in appropriate buffer containing ATP. The total volume was 
20 µl and incubation time was 1h at 37° or alternatively o/n at 16°C. Subsequently DNA was 
used to transform bacteria. Cloning of PCR products was performed by using the TOPO-TA 
cloning kit and the Zero-Blunt TOPO PCR cloning kit according to the manufacturer 
suggested procedure. 
 
4.4.4 RNA isolation  
Isolation of RNA out of human cells was performed using the RNeasy Mini Kits from Qiagen 
following manufacture’s protocol. 
 
4.4.5 Reverse transcription 
The enzyme reverse transcriptase was used to generate DNA complementary to RNA 
templates (cDNA). 2 µg RNA were diluted in water to a volume of 14 µl and pre-incubated 
with 1 µg random primer for 10 min at 56°C. Per reaction 4.5 µl reaction mix containing 1 µl 
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dNTS (100 mM), 2 µl 10 x buffer, 0.5 µl RNase Out (40 U/µl) and 1 µl AMV reverse 
transcriptase were added. Aliquots were incubated at 42°C for 40 min and 2 min at 95°C. 
 
4.4.6 DNA amplification by polymerase chain reaction (PCR) 
The technique of polymerase chain reaction (PCR) was used to amplify DNA segments. For 
each segment a pair of specific oligonucleotide primers, one 5´-forward primer and one 3-
reverse primer, were designed and used.  100 ng of DNA template were mixed with 10 pmol 
of each primer, 0.08 mM dNTP mix, 2,5 U Taq DNA polymerase or 1 µl Pfu DNA polymerase, 
respectively, and diluted in corresponding buffer containing 1,5 mM MgCl2 to an overall 
volume of 50µl. Reaction protocol was started with an initial denaturation step at 95°C for 5 
min and continued with 20-30 amplification cycles, each consisting of 30 s of denaturation 
at 95 °C, 30 s annealing at 58°C and 3 min elongation at 72°C. Finally reaction was 
terminated by onetime heating to 72°C for 5 min and the PCR products were purified using 
the PCR Purification Kit from Qiagen following manufacturer’s protocol. In case of PCR was 
performed subsequent reverse transcription control primers (β-actin forward, β-actin 
reverse) were added to the reaction mixture.  
 
4.4.7 Generation of expression constructs  
SMUDO full-length construct was previously cloned from cDNA libraries (DKFZ) by Ilka 
Dauth using PCR and subcloning of PCR products into pCDNA3 vector.  By further 
subcloning via BamHI, XbaI restriction sites various tagged SMUDO full-length expression 
constructs were created (GFP-SMUDO, Myc-SMUDO, Flag-SMUDO). Due to the size of the 
SMUDO open reading frame (ORF) of about 6 kb cloning procedure pointed out to be 
difficult and several times cloning had to made in two steps, which included a third 
restriction site that was dependent on the destination vector used. SMUDO constructs 
lacking the MutL or the SMC region, respectively, were produced by PCR and subcloning into 
pEGFP-C1, pCMV-3Tag1A and pCMV-Tag3B vectors.  Several GST-tagged SMUDO fragment 
expression constructs were produced by subcloning fragments of the SMUDO ORF out of 
pCR4-TOPO and pCR-Blunt vectors into pGEX-4T1 vector. Lentiviral knock constructs were 
produced by cloning siRNA sequences into pGLenti vectors. 
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4.4.8 Northern blot analysis 
For production of a SMUDO Northern blot probe a part of SMUDO’s nucleotide sequence was 
digested with HindIII and NheI. The generated fragment was 1724 bp in size (SMUDO bp 
2194-3917). Labeling of the probe was done by using the Fermentas Label Plus DNA 
labeling kit, where the instructions of the manufacturer have been followed. The probe was 
applied to a membrane pre-hybridized with human tissue specific RNA (Frstchoice™ 
Humanblot1 from Ambion). The instructions of the manufacturer have been followed. 
ULTRAhyb hybridization solution and Northern Max low stringency wash solution from 
Ambion were used for the procedure. 
 
4.4.9 Yeast two-hybrid screening 
The yeast two-hybrid screens were performed at PanBioNet Company. 
 
4.4.10 DNA sequencing 
DNA sequencing was performed at GATC Biotech AG (Konstanz, Germany) or at the Genomic 
and Proteomics Core Facility of the DKFZ. 
 
4.5 Microscopy 
4.5.1 Immunofluorescence microscopy 
To visualize endogenous proteins for microscopy they were indirectly stained with 
fluorescent dyes using adequate antibodies. Cover slips were placed in 24-wells and U2OS 
cells were seeded on it. For pre-extraction of loose intracellular material cell were washed 
with PBS and afterwards with cytoskeletal buffer (CSK buffer) before incubated with CSK 
buffer supplemented with 0.5 % Triton X-100 for 2 min at RT. Cell were washed again with 
pure CSK buffer and PBS. For fixation cells were incubated in PBS containing 4 % 
paraformaldehyde (PFA) for 20 min, RT. Residues of PFA were removed by washing cover 
slips two times with PBS. Without previous pre-extraction cells had to be permeabilized by 
incubation in PBS supplemented with 0.5 % Triton X-100 for 5 min at RT.  Primary 
antibodies directed against the endogenous proteins were diluted in PBS and per cover slip 
a 70 µl drop was placed on Parafilm. Cover slips were put onto drops with the side covered 
with cells directed to the antibody dilution. For each primary antibody used the dilution 
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factor was individually adjusted. Incubation was carried out over night at 4°C while cover 
slips were stored in a non-transparent container. To avoid evaporation of antibody dilution 
humidity inside the container was increased by placing wet tissues inside. Next, cover slips 
were washed five times with PBS, each time for at least 5 min, and dilution of secondary 
dye-coupled antibodies directed against the primary antibodies was prepared. The typical 
dilution factor for secondary antibodies was 1:450 and solution was additionally 
supplemented with Hoechst 33258 dye to label DNA. Incubation of the cells for 45 min was 
followed by five times washing with PBS and embedding of cover slips into Mowiol on an 
object slide. Mowiol was hardened by air drying o/n and sealed with nail enamel. 
For microscopy studies of overexpressed fluorescent fusion proteins expression plasmid of 
the protein of interest was transfected into cells by one of the transfection methods 
described earlier. Pictures have been taken with an Olympus IX81 confocal microscope. For 
conventional fluorescent pictures the microscope pinhole diameter was greater than 150 
nm, while it was 80-100 nm for confocal pictures. Olympus FluorView software was used for 
microscope control. 
 
4.5.2 Fluorescence recovery after photobleaching (FRAP) 
The technique of Fluorescence recovery after photobleaching (FRAP) was used to quantify 
diffusion of GFP tagged SMUDO protein trough the nuclear membrane of mammalian cells. 
Cells were seeded in live cell chambers which have a base made of silica glass to allow laser 
application. Cells were transfected with expression plasmid and 24 h after transfection 
standard growth medium was exchanged by medium lacking phenol red, since this pH 
indicator interferes with fluorescent assays. For picture documentation and fluorescent 
bleaching an Olympus IX81 confocal microscope and attached laser emitters have been used. 
Olympus FluorView software was used for microscope and laser control. For compartment 
bleaches 30 frames with an interval of 20 seconds have been taken. The scan time was 3.2 
seconds per frame. Bleaching was applied by a 488 nm laser at 100% emission for 6 frames. 
One frame was taken before bleaching. The timespan for a complete procedure was 9 
minutes and 50 seconds. For point bleaches 30 frames have been taken at a free run (fast as 
possible). The scan time was 1.6seconds per frame. Bleaching was applied by a 488 nm laser 
at 100% emission for 2 frames at the tornado mode (downwards spiral of laser focus). One 
frame was taken before bleaching. The timespan for a complete procedure was 50 seconds.  
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4.6 Bioinformatics 
For software analysis of nucleotide and protein sequences the BLAST server 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) and the correlated NCBI Conserved Domains tool 
(http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi) were used. In addition, free 
software available at the ExPASy tool server (http://expasy.org/tools) was used. In detail, 
the NetES 1.1 server (http://www.cbs.dtu.dk/services/NetNES/) was used to predict 
nuclear localization signals, the PredictNLS software was used to predict nuclear 
localization signals (http://www.cubic.columbia.edu.cgi.var.nair.resonline.pl), Compute 
pI/Mw software was used to calculate the molecular weight of SMUDO protein and SUMOsp 
prediction software was used to find potential SUMOylation sites inside SMUDO’s amino 
acid sequence. Sequence alignments were carried out at the CLUSTALW server 
(http://www.genome.jp/tools/clustalw/). 
 
4.7 Methods in protein biochemistry 
4.7.1 Preparation of total cell lysates 
Cell transfected with expression plasmid and / or treated with agents as well as 
untransfected and untreated control cells were lysed in various types of buffers for different 
applications. For biochemical analysis of cellular protein total cell lysates were prepared 
using NP-40 / 1 % SDS or Triton X-100 lysis buffer, respectively. Adherent cells were 
washed twice with ice-cold PBS and scraped off cell culture dishes using rubber policemen. 
Detached cell were taken up in PBS and collected by centrifugation at 13,000 rpm, 4°C, for 5 
min, resupension in about 300 µl PBS, followed by transfer into 1,5 ml micro tubes and once 
again centrifugation for 5 min at 13,000 rpm and 4°C. 100-400 µl of lysis buffer were given 
on cells and suspension was chilled on ice for 5 min before sonicated (output 2, NP-40 / 1 % 
SDS buffer: 3 x 10 sec, Triton X-100 buffer: 2 x 8 sec) while kept on ice. Lysates were then 
centrifuged at 13,000 rpm and 4°C for at least 30 min to separate soluble lysates from 
insoluble cellular remains. If necessary, 3 µl of the lysates were taken for determination of 
protein concentration. Lysates were mixed with 5 x SDS sample buffer, that contains β-
mercaptoethanol to reduce disulfide bonds, and heated at 95°C for 5 min to denature and 
stabilize proteins. Lysates were directly used for SDS-PAGE or placed at -20°C for storage. 
For immunoprecipitation cells were lysed in NP-40 / 1 % SDS buffer and handled as 
described below (4.7.9). 
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4.7.2 Determination of protein concentration and purity 
To allow equal loading of SDS-PAGE gels and equal settings for endogenous 
immunoprecipitations, protein concentration of lysates was determined by using the BCA 
Protein Assay Kit (Thermo Fisher Scientific) following the manufacturer’s instructions and 
measuring absorbance at 570 nm in a plate reader (Labsystems Multiskan Ms). Reference 
curves were regenerated by measuring absorbance of BSA protein standard solutions. 
Purity and concentration of proteins isolated out of bacteria was checked by SDS-PAGE gel 
and subsequent Comassie staining. Again BSA standard solutions were used as reference. 
 
4.7.3 Subcellular fractionation 
This method was used to obtain separated protein extracts from nuclei and cytoplasmic 
compartments of mammalian cells. For one sample two to three 10 cm dishes of confluent 
adherent cells were harvested as described above, resuspended in a suitable volume of PBS 
and the third part was taken to make total cell lysates for control using NP-40 / 1 % SDS 
buffer. The remaining cells were further handled for fractionation. After pelletizing by 
centrifugation they were taken up in 100 µl cellular fractionation buffer A, that was 
supplemented with protein inhibitors, and held on ice for 12 min. To break cellular 
membranes, 6.25 µl of 10 % NP-40 solution was added and aliquots were immediately 
mixed by vortexing for 10 sec. Subsequently lysates were centrifuged for 1 min at 13,000 
rpm, 4°C, and supernatant was transferred into a new 1.5 ml micro tube (cytoplasmic 
fraction), at that clear separation from pellet was critical. Remaining pellet was washed on 
time with PBS, resuspended in 100 µl NP-40 / 1 % SDS, sonicated and centrifuged at 13,000 
rpm and 4°C for at least 30 min. Supernatant was transferred to a new 1,5 ml micro tubes 
(nuclear fraction). Both, cytoplasmic and nuclear fraction were mixed with 5 x SDS sample 
buffer and headed at 95°C for 5 min. For analysis the control lysates as well as equal 
amounts of cytoplasmic lysates and nuclear lysates were loaded on SDS-PAGE gel. 
 
4.7.4 SDS-polyacrylamide gel electrophoresis 
Sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis under denaturing 
conditions was used to separate proteins according to their electrophoretic mobility. For 
this lysates were prepared as described before (see 4.7.1) and desired protein amount or a 
distinct volume was loaded on 4-20 % PAGEr Gold Precast gel (Lonza). Electrophoresis 
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procedure was accomplished in apparatuses purchased from Bio Rad Laboratories 
(Hercules, USA). 
 
4.7.5 Coomassie blue staining 
To stain GST-fusion proteins in SDS-gels, they were incubated in Coomassie Brilliant Blue 
(CBB) R250 staining solution. SDS-gel covering solution was heated in a microwave oven for 
about 1 min to immobilize and stain proteins. Staining solution was removed and gels were 
rinsed with waster to dispose excess stain. Afterwards gels were incubated in destaining 
solution, which was renewed 1-2 times, until background was reduced to acceptable level 
and protein bands were clearly visible. 
 
4.7.6 Drying of SDS-polyacrylamide gels 
For long term storage, gel could be dried and sealed into plastic foil. For this purpose gels 
were placed on wet Whatman filter paper, covered with plastic foil and dried for 1-2 h at 
80°C in a vacuum gel dryer (Bio Rad). 
 
4.7.7 Western blot (Immunoblotting) 
Proteins were blotted from a SDS-gel onto a PVDF membrane (Hybond-P) using wet 
electrophoretic transfer method. To do this PVDF membrane was activated in pure 
methanol for 10 sec and equilibrated in wet blot buffer besides SDS-gels, Whatman paper 
and fiber pads. SDS-gel was placed on the membrane and both parts were covered with 
Whatman paper and fiber pads. The gel/membrane sandwich was assembled in a holder 
cassette and placed into a transfer apparatus (Bio Rad).  Protein transfer was carried out at 
380 mA and 4°C for 1 h and 20 min. After that transfer efficiency was checked by Poncau S 
staining. Subsequently membrane was washed with deionized water and incubated in 5 % 
fat-free milk powder in TBS-T buffer for at least one 1 h to block free unspecific binding 
sites. Primary antibody was diluted in 5 % BSA or 5 % fat-free milk/TBS-T buffer, 
respectively, and membranes were incubated with constant agitation either at RT for 2-4 h 
or o/n at 4°C. To remove excess primary antibody membrane was washed 3 x 10 min with 
TBS-T. Horseradish peroxidase (HRP) coupled secondary antibody was diluted 1:20,000 in 5 
% fat-free milk/TBS-T buffer and membrane was incubated for 30-60 min at RT with 
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agitation. Again membrane was washed for at least 3 x 10 min with TBS-T, placed in an X-
ray cassette and moistened with a 1:1 mixture of the SuperSignal West Dura Extended 
Duration Substrate solutions (Thermo Scientific). Proteins were indirectly detected by 
exposition of X-ray film to the peroxidase generated chemiluminescence. 
 
4.7.8 Purification of recombinant proteins 
Bacteria cultures were harvested by centrifugation or thawed on ice, if had been stored at -
80°C. Pellet was taken up in ice-cold PBS and cells were held on ice during all following step. 
Fist, cells were broken by sonication (3 x 15 sec, output 3) and Triton X-100 was added to a 
final concentration of 1 %. After 10 min cell extracts were sonicated again (3 X 15 sec, 
output 3). Unbroken cells and cellular remains were separated by centrifugation at 13,000 
rpm and 4°C for 30 min (Sorvall ultracentrifuge, SS34 rotor). Glutathione SepharoseTM 4 Fast 
Flow was added to supernatant and aliquot were incubated for at least 2 h on a rotator. 
Speharose was washed 3 x with PBS. For experiments either sepharose-coupled proteins 
were used or proteins were eluted from sepharose prior performance by using reduced 
glutathione (final conc. 8 mM). Elution was carried in 1.5 ml micro tubes on a rotator for 1 h. 
After short centrifugation (2 min at 3,000 rpm, 4°C) supernatant was transferred into a new 
1.5 ml micro tube. Finally the solution containing the protein was dialyzed o/n against a 
1,000-fold volume of dialysis buffer. Proteins were directly used for experiment or stored at 
4°C. 
For purification of histidine-fusion proteins bacteria were harvested suitable time after 
induction of protein expression and resuspended in HEMGN buffer. Cells were broken by 
sonication and aliquots were supplemented with NP-40 (final conc. 0.1 %) and chilled on ice 
for 10 min before sonicated again. Unbroken cells and cellular remains were separated by 
centrifugation at 13,000 rpm and 4°C for 30 min. Ni-NTA agarose (Qiagen), KCl (final conc.: 
0.2 M) and imidazole (final conc.: 10 mM) were added to supernatant and aliquots were 
incubated on a rotator at 4°C for 2 h. Afterwards agarose was washed 3 x with HEMGN 
buffer, 0.2 M, 10 mM imidazole. For elution agarose was transferred to a new 1.5 ml micro 
tube histidine elution buffer was added and suspension was incubated on a rotator for 1h. 
After centrifugation (2 min at 3,000 rpm, 4°C) supernatant was transferred into another 1.5 
ml tube and the solution containing the protein was dialyzed o/n against a 1,000-fold 
volume of HEMGN buffer. Proteins were directly used for experiment or stored at -80°C 
after shock freezing. 
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4.7.9 Immunoprecipitation and Co-Immunoprecipitation 
To perform immunoprecipitation assays, total cell lysates were prepared as described in 
section 4.7.1. Lysates were pre-cleared by adding 25 µl protein A/G Plus Sepharose beads 
(Santa Cruz, USA) and incubation on a rotator for 1 h at 4°C, to do this the volume of each 
aliquot had been previously adjusted to 750 µl with lysis buffer to ensure proper mixing. 
Solid phase was separated by centrifugation for 2 min at 3,000 rpm, 4°C, and discarded. 
Supernatants were incubated with 5-10 µg of specific antibody on a rotator for 4-14 h at 4°C. 
Subsequently 25-30 µl protein A/G Plus Sepharose beads were added and lysates were 
incubated again for 1 h to bind antibodies to beads. Sepharose beads were washed 3 times 
by adding each time 750 µl lysis buffer, gently mixing and short centrifugation (3,000 
rpm,4°C, 2min). Then lysis buffer was removed and beads were resuspended in 1 x SDS 
sample buffer and heated at 95°C for 5 min before analyzed on SDS-PAGE gel and Western 
blot. For storage samples were kept at -20°C. For Immunoprecipitaion of overexpressed 
Flag-tagged proteins, Flag M2 agarose beads were used following the manufacturer’s 
protocol. 
 
4.7.10 In vitro Translation of 35S-labeled Proteins 
Radioactive labeling of proteins with L- 35S-methionine for pulldown experiments was 
accomplished by using the TNT Coupled Reticulolysate Lysate system (Progema).  
Reticulolysates were aliquoted on ice in total volumes of 50 µl and mixed with 2µg 
plasmid DNA containing a T7 or T3 promoter and corresponding RNA polymerase. After 
incubation for 90 minutes at 30°C samples were directly used for pulldown experiments 
or stored at -80°C. 
 
4.7.11 GST pulldown assay 
To examine protein in vitro interaction, GST pulldown assays have been performed. For 
experiments recombinant GST-HIPK2ΔC fusion protein and in vitro generated and 35S-
labeled SMUDOΔN were incubated in 750 µl PBS supplemented with 0.1 % NP40, 1 mM 
sodium orthovanadate, protease inhibitor cocktail and gluthation sepharose  at 4°C for 1.5 
hours on an orbital shaker. Sepharose was washed 3 times with 750µl interaction buffer, 
resuspended in 1xSDS sample buffer and analyzed by SDS-PAGE. For one pulldown 
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experiment 3-5µg of GST fusion proteins and 10µl of in vitro translated proteins were used. 
Proteins were stained with coomassie and radioactive signal were amplified by incubation 
in amplifier solution (Amplify Solution, Amersham) for 15 min. Finally radioactive signals 
were detected on an X-ray film. 
 
4.7.12 In vitro phosphorylation experiments 
To test phosphorylation of SMUDO by HIPK2 in vitro phosphorylation experiments were 
performed. For this purpose Flag-tagged HIPK2 was overexpressed in 293T cells and 
subsequently precipitated or His- tagged HIPK fusion protein was purified from E.coli.  
GST-SMUDO fragments were generated and precipitated as described before (4.7.8). 
Proteins were incubated in a total volume of 30 µl Ser/Thr kinase buffer supplemented with 
40µM [γ-S]-ATP and 5 µCi [γ-32P]-ATP for 30 min at 30°C. Typically, 1-5 µg of substrates 
(SMUDO fragments) and 0.5-1 µg of rHis-HIPK2 were applied. Reaction was stopped by 
adding 7.5ml 5 x SDS sample buffer and boiling at 95°C for 5 min. Samples were separated 
by SDS-PAGE. After gel fixation and staining with coomassie, gels were dried and analyzed 
with X-ray films. 
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4.8 Materials 
4.8.1 Materials and Kits 
Material Manufacturer 
1.5 ml reaction tubes Sarstedt AG 
10 cm cell culture dishes Greiner & TPP AG 
15 ml reaction tubes Greiner 
2 ml reaction tubes Sarstedt AG 
50 ml reaction tubes Falcon 
6 cm cell culture dishes Greiner & TPP AG 
6-well plates Nunc GmbH 
96-well plates Falcon 
Firstchoice Humanblot 1 Ambion 
Complete protease inhibitor cocktail Roche 
Cryo vials Roth 
Fugene Roche 
Glutathion-Sepharose Amersham Biosciences 
HiPerFect Qiagen 
LipofectamineTM 2000 Invitrogen 
Mg/ATP slolution Boston Biochem 
Nickel-NTA-Agarose Qiagen 
PCR tubes Nerbe 
Pierce ECL-Kits Thermo Fischer Scientific 
Pierce® BCA Protein Assay Kit Thermo Fischer Scientific 
Protein A/G Plus Sepharose Santa Cruz 
PVDF-membrane „HybondTM-P” GE Healthcare 
QIAGEN® Plasmid Maxi Kit Qiagen 
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Material Manufacturer 
QIAprep® Spin Miniprep Kit Qiagen 
QIAquick® Gel Extraction Kit Qiagen 
TNT® Coupled Reticulocyte Lysate System Promega 
TOPO® TA Cloning® Kit Invitrogen 
X-ray films „Fuji Super FX“ FUJIFILM 
Zero Blunt® TOPO® PCR Cloning Kit Invitrogen 
 
4.8.2 Chemicals 
Reagent Manufacturer 
-Glycerophosphate AppliChem 
[-32P]-ATP Perkin-Elmer 
[-S]-ATP Roche Diagnostics 
5-Fluorouracil Sigma Aldrich 
Adriamycin (doxorubicin) Merck Biosciences 
Ammoniumperoxysulfate (APS) Sigma Aldrich 
Ampicillin Gerbu 
ATP US Biological 
BSA Servia 
Coomassie brilliant blue G250 BioRad 
Dithiothreitol US Biological 
Glutathion Sigma Aldrich 
Imidazole Sigma Aldrich 
IPTG Roth 
Kanamycin Gerbu 
L-35S-Methionin Perkin-Elmer 
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Reagent Manufacturer 
MG-132 US Biological 
Phenylmethanesulphonyl fluoride (PMSF) Sigma Aldrich 
Sodium orthovanadate Sigma Aldrich 
Standard chemicals were purchased from Sigma Aldrich, Roche Diagnostics, Roth, Gerbu, 
Biozol and Merck. 
 
4.8.3 Proteins and enzymes 
Protein/Enzyme Manufacturer 
ApaI New England BioLabs 
BamHI New England BioLabs 
BglII New England BioLabs 
BmpI New England BioLabs 
BspEI New England BioLabs 
BssSI New England BioLabs 
Calf intestinal phosphatase (CIAP) New England BioLabs 
DpnI New England BioLabs 
DrdI New England BioLabs 
EagI New England BioLabs 
EcoRI New England BioLabs 
HindIII New England BioLabs 
Kpn! New England BioLabs 
MBP, dephosphorylated Millipore (Upstate®) 
NaeI New England BioLabs 
NcoI New England BioLabs 
NheI New England BioLabs 
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Protein/Enzyme Manufacturer 
NotI New England BioLabs 
NspI New England BioLabs 
Pfu DNS Polymerase Fermentas 
PstI New England BioLabs 
SacII New England BioLabs 
T 4 ligase New England BioLabs 
Taq DNS Polymerase Invitrogen 
Trypsin/EDTA Invitrogen (GIBCO®) 
XcmI New England BioLabs 
XhoI New England BioLabs 
XmaI New England BioLabs 
 
4.8.4 Markers 
Marker Manufacturer 
PageRulerTM Plus Prestained Protein Ladder Fermentas 
Prestained Protein Molecular Weight Marker Fermentas 
GeneRulerTM 1kb DNA Ladder Fermentas 
 
4.8.5 Buffers, Solutions and Media 
Buffers and Solutions 
Buffer Ingredient Concentration 
TAE buffer (50x) Tris-acetate, pH 8.0 2 M 
 EDTA 50 mM 
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Buffer Ingredient Concentration 
DNA sample buffer (6x) Formamide 85% (v/v) 
 EDTA, pH 8.0 10 mM 
 Bromphenol blue 1 mg/ml 
 Xylen cyanol 1 mg/ml 
PBS Na2HPO4/KH2PO4, pH 7.4 12 mM 
 NaCl 137 mM 
 KCl 2.7 mM 
TBS (20x) Tris-HCL, pH 7.5 500 mM 
 NaCl 1.5 M 
TBST 1x TBS buffer  
 Tween 20 0.1% (v/v) 
SDS sample buffer (5x) Tris-HCL, pH 6.8 62.5 mM 
 Glycerol 40% (v/v) 
 ß-Mercaptoethanol 5% (v/v) 
 SDS 2% (w/v) 
 Bromphenol blue 0.5% (w/v) 
SDS stacking gel Tris-HCL, pH 6.8 125 mM 
 Acrylamid-bisacrylamid (37.5:1) 5% (v/v) 
 SDS 0.1% (w/v) 
 APS 0.04% (v/v) 
 TEMED 0.075% (v/v) 
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Buffer Ingredient Concentration 
SDS resolving gel Tris-HCL, pH 8.8 350 mM 
 Acrylamid-bisacrylamid (37.5:1) 6-12.5% 
 SDS 0.1% (w/v) 
 APS 0.04% (v/v) 
 TEMED 0.075% (v/v) 
SDS-Laufpuffer (10x) Tris-Base, pH 8.3 250 mM 
 Glycin 1.92 M 
 SDS 1% (w/v) 
Ponceau S staining solution Ponceau S 0.5% (w/v) 
 Acetic acid 1% (v/v) 
Coomassie staining solution Coomassie-Brilliantblau R 250 0.5% (w/v) 
 Methanol 45% (v/v) 
 Acetic acid 10% (v/v) 
Coomassie destain solution Methanol 45% (v/v) 
 Acetic acid 10% (v/v) 
Transfer buffer Tris 25 mM 
 Glycin 190 mM 
 Methanol 10% (v/v) 
HEMGN buffer Hepes-KOH, pH 8.0 25 mM 
 KCl 100 mM 
 MgCl2 12.5 mM 
 Glycerol 10 % 
 EDTA 0.1 mM 
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Buffer Ingredient Concentration 
Histidine elutionpuffer HEMGN buffer  
 KCl 0.2 M 
 Imidazole 250 mM 
GST elution buffer Hepes, pH 7.5 30 mM 
 NaCl 150 mM 
 GSH 8 mM 
 Dithiothreitol 2 mM 
GST dialysis buffer Hepes, pH 7.5 30 mM 
 NaCl 150 mM 
Ubiquitinierungspuffer Tris, pH 7.4 50 mM 
 MgCl2 5 mM 
 Dithiothreitol 2 mM 
Kinase buffer Hepes, pH 7.4 20 mM 
 NaCl 150 mM 
 -Glycerophosphate 25 mM 
 MgCl2 20 mM 
 NaF 10 mM 
 Dithiothreitol 2 mM 
 Na3VO4 1 mM 
HBS-Puffer (2x) HEPES, pH 7.05 42 mM 
 Na2HPO4 1.4 mM 
 NaCl 274 mM 
 KCl 10 mM 
 Dextrose (D(+)-Glucose) 12 mM 
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Buffer Ingredient Concentration 
Fractionation buffer A HEPES, pH 7.9 10 mM 
 KCl 10 mM 
 EDTA 0.1 mM 
 EGTA 0.1 mM 
NP40 buffer* Tris-HCl, pH 7.4 20 mM 
 NaCl 150-250 mM 
 NaF 25 mM 
 Glycerol 10 % (v/v) 
 EDTA 5 mM 
 NP40 1 % (v/v) 
   
Totex buffer* HEPES-KOH, pH 7.9 20 mM 
 NaCl 350 mM 
 Glycerol 20% (v/v) 
 NP40 1% (v/v) 
 MgCl2 1 mM 
 EDTA 0.6 mM 
1% SDS lysis buffer* Tris-HCl, pH 7.4 20 mM 
 NaCl 150-250 mM 
 NaF 25 mM 
 EDTA 5 mM 
 NP40 1% (v/v) 
 SDS 1% (v/v) 
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Buffer Ingredient Concentration 
0.1% SDS lysis buffer* Tris-HCl, pH 7.4 20 mM 
 NaCl 150-250 mM 
 NaF 25 mM 
 EDTA 5 mM 
 NP40 1% (v/v) 
 SDS 0.1% (v/v) 
*Lysis buffers were supplemented with 1mM sodium orthovanadate, 0.1 mM PMSF, 10µM 
MG-132 and Complete protease inhibitor cocktail before used. 
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Growth media 
Medium Ingredient Concentration 
DMEM Dulbecco’s Modified Eagle Medium (GIBCO®)  
 Fetal calf serum (FCS) 10% (v/v) 
 HEPES 10 mM 
 L-Glutamine 2 mM 
 Sodium pyruvate 1 mM 
 Penicillin 50 U/ml 
 Streptomycin 50 µg/ml 
 (Non-essential amino acids) 1% (v/v) 
Opti-MEM Serum reduced medium (GIBCO®)  
LB medium Yeast extract 0.5% (w/v) 
 Tryptone 1% (w/v) 
 NaCl 1% (w/v) 
 
4.8.6 Eukaryotic cell lines 
Cell line Distributor 
HEK293T ATCC 
H1299 ATCC 
MCF7 ATCC 
HCT116 ATCC 
U2OS ATCC 
HCT116 ATCC 
GM03491 ATCC 
HT1080 ATCC 
Hep3B Coriell Repositories 
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4.8.7 Bacterial strains 
E. coli Genotype Distributor 
TOP10 F- mcrA (mrr-hsdRMS-mcrBC) 80lacZM15 lacX74 recA1 
araD139 (ara-leu)7697 galU galK rpsL (StrR) endA1 nupG 
Invitrogen 
BL21 B F- dcm ompT hsdS(rB-mB-) gal Invitrogen 
 
4.8.9 cDNA clones 
Designation  Reference 
DKFZ686O0631  DKFZ 
RZPD434k063  DKFZ 
 
4.8.10 Expression vectors 
Vector backbone Tag Insert 
pCDNA3-Flag 1 x Flag HIPK2 
pCMV-Tag3B (mod.) 1 x Myc SMUDO, SMUDOΔMutL, 
pCMV-3Tag1A 3 x Flag SMUDO, SMUDOΔSMC 
pDEST-HA 1 x HA  SMUDO 
pEGFP-C1 eGFP SMUDO, SMUDOΔMutL, 
SMUDOΔSMC 
pGTB9-GW GAL4 DNA binding domain SMUDO 
pGEX-4T GST SMUDOaa1-391, SMUDOaa252-
735, SMUDOaa728-1311, 
SMUDOaa1291-1998 
pGLenti (pLentiLox3.7) - shSM1, shSM3 
pSUPER - shSM1, shSM3 
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4.8.11 Synthetic oligonucleotides 
Primers for PCR 
Designation Sequence (5’  3’) 
Moc-Klon-1-For GGATCCATGGCAGCGGCGGACGGC 
Moc-Klon-1-KpnI-Rev AGATCTGGTTGACAATCTTAGTAGGTACCTTC 
Moc-Klon-1b-For GGATCCATGATAAGCAAACCTGCAGATTC 
Moc-Klon-1-Rev TCTAGATCCTGGAAGCTTTTGCATTGCTTC 
Moc-Klon-2-For GGATCCATGCAAAAGCTTCCAGGAACAAG 
Moc-Klon-2-Rev TCTAGAGGCATGAGCTTTAAATTGCTAG 
Moc-Klon-3-For GGATCCATGCCAGCACCGGTACAACATG 
Moc-Klon-3-Rev TCTAGATCACCTATTTTGTCTTGTAGCTTC 
Moc-RT-2-For CAACCAGAACACATACAGTACTTG 
Moc-RT-2-Rev CTCTAGCTGCTTTCTCAAGTATG 
Actin-RT-For CCTCGCCTTTGCCGATCC 
Actin-RT-Rev GGATCTTCATGAGGTAGTCAGTC 
SMUDO-429-Rev CGATCGAAATGGCAAAGGATTTCC 
SMUDO-646-For CGATCGTCAGGATATGTTCGTCCAGTACC 
SMUDO-1203-Rev CGTCTGCATGTCGTCTTGTATTT 
SMUDO-4451-For TGCCTAATCAACCTGTGAAGTTAG 
SMUDO-4998-Rev CCGCGGGGCCTCTTTTAATCTTGCTTCTT 
SMUDO-5464-For CCGCGGCATTGTGAAACAGTATTTGGTATGC 
SMUDO-5997-Rev TCTAGATCACCTATTTTGTCTTGTAGCTTCTC 
The listed oligonucleotide primers were purchased from Invitrogen Company. 
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siRNAs for RNA interference 
Designation Target sequence (5’  3’) 
siSMUDO1 CGTATTTTGTCTACTCTTT 
siSMUDO2 TGTTGTTCATCCTTTCTTT 
siSMUDO3 CAAATACCTAGAACTCGAT 
siMutL AATGATGAAACACAAGGAAAA 
siLuci AACGTACGCGGAATACTTCGA 
RNA oligonucleotides were purchased from Qiagen Company. 
 
4.8.12 SMUDO Northern blot probe 
Sequence of the SMUDO Northern blot probe in 5’-3’ orientation (SMUDO bp 2194-3917): 
aagcttccaggaacaagccatggagggtcaaagaaactcctggttgagctcaaagttattttacattcttcaagtggaaataa
agagattatttcgcatattagtcaacatggaggaaaatggccttactggtttaaaaaaatggaaaatattcagaagttgggga
attataccttgaaattacaagttgtgttgaatgaaagtaatgcagacacttatgcaggaagaccactaccatctaaagcaatt
aagttttctgttaaagagggtaagccagagaaattttcatttggtcttctggatcttccttttcgtgttggagttccatttaa
tatccctctggagtttcaggatgaatttggtcataccagtcaactagtaactgatattcagccagttcttgaagcaagtggtt
tatctttacattatgaagaaataaccaaaggaccaaattgtgtaattcgaggtgttacagccaagggccctgtaaactcttgt
caaggcaagaattataatctgaaggttactctgcctggcttaaaagaagactcacagattttgaaaattagattactacctgg
tcaccctcgtcgactgaaagtgaaacctgattctgaaattttagttatagaaaatggaacagctttcccatttcaggtggaag
ttttagatgaatcagacaacataacagcacaaccaaaattgattgttcattgtaagttttcaggtgctccaaaccttccagtc
tatgttgtagattgcagtagttctggaaccagtattttaacaggatctgcaattcaagttcagaatattaaaaaagaccagac
gcttaaagcaagaattgaaatacctagttgtaaagatgtggcacctgtggagaagactattaagttgcttcccagtagccatg
ttgcaagactacaaatattcagtgtagaaggacaaaaggcaattcagatcaaacatcaggatgaggttaattggatagcgggt
gatattatgcataatcttatttttcaaatgtatgatgaaggagaaagagaaatcaatataacatcagctttagcagaaaaaat
taaagttaattggactcctgagattaacaaagaacacttgctacagggtctgcttcctgatgtgcaagtaccaacatctgtaa
aagatatgcgctattgccaggtttcattccaagatgatcatgtgtctttggaaagtgcgtttacagtaagaccacttcctgat
gaacctaaacatttaaaatgtgaaatgaaaggaggaaaaacagtacagatgggccaagagcttcaaggagaagtagttataat
aattacagatcagtacggaaatcagattcaagcattttcaccaagttctttatcttctttgtcaattgctggggttggacttg
atagctcaaatttgaaaacaacctttcaggaaaacacacagagtataagtgtaagaggcatcaaatttattccaggtcctcct
ggaaataaggatctttgttttacttggcgtgagttttctgactttattcgagtgcaactaatttctggacctcctgctaaact
tctccttatagactggccagaactaaaggagtccattccagtgattaatggaagagatttacagaaccctattattgttcaac
tttgtgatcagtgggataatccagcaccggtacaacatgttaaaataagtcttacaaaagctag 
 
4.8.13 Synthetic Peptides 
Designation Sequence (NC) 
SMUDO 16mer (aa319-335) NH2-TFSCNKIKDNDKEDGC-COOH 
SMUDO 17mer (aa854-871) NH2-KCNDSLRHSPKVETTDC-COOH 
Synthetic peptides were produced at Eurogentic and used for generation of anti-SMUDO 
antibodies. 
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4.8.14 Antibodies 
Primary antibodies 
Designation Species Manufacturer 
Aktin Mouse Sigma 
ATM (2C1) Mouse Abcam 
ATR (AB-2) Rabbit Calbiochem 
Chk1 Rabbit Cell Signaling 
Chk2 Rabbit Cell Signaling 
Flag (M2) Mouse Sigma 
GFP Rabbit Santa Cruz 
GST (Z-5) Rabbit Santa Cruz 
HA (12CA5) Mouse Roche 
HA (3F10) Rat Roche 
HIPK2#88 Rabbit Eurogentec 
Myc (9E10) Mouse Santa Cruz 
p53 (DO-1) Mouse Santa Cruz 
p53 (FL-393) Rabbit Santa Cruz 
PARP1 Mouse Santa Cruz 
pS46 (p53) Rabbit Cell Signaling 
SMC1 Rabbit Bethyl Laboratories 
SMC2 (BL548) Rabbit Laboratories 
SMC5 (BL1118) Rabbit Laboratories 
SmcHD1 Rabbit Abcam 
SMUDO16A Rabbit Eurogentec 
SMUDO16B Rabbit Eurogentec 
SMUDO16C Rabbit Eurogentec 
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Designation Species Manufacturer 
SMUDO16D Rabbit Eurogentec 
SMUDO17A Rabbit Eurogentec 
SMUDO17B Rabbit Eurogentec 
SMUDO17C Rabbit Eurogentec 
SMUDO17D Rabbit Eurogentec 
γH2-AX Rabbit Cell Signaling 
 
Secondary antibodies, peroxidase-coupled 
Designation Species Manufacturer 
Rat Goat Dianova 
Mouse Goat Dianova 
Rabbit Goat Dianova 
 
4.8.15 Devices 
Type of device Manufacturer 
Incubation shaker „Minitron“ Infors GmbH 
CO2-incubator „CB 210“ Binder 
Clean bench „Gelaire BSB 4A“ Flow Laboratories 
Ultracentrifuge „RC5C“ Sorvall Instruments (DuPont) 
Cooling centrifuge „Varifuge RF“ Heraeus Sepatech 
Table centrifuge „Pico 17“ Thermo Fischer Scientific 
Table centrifuge „Biofuge® fresco“ Heraeus 
Thermomixer „comfort“ Eppendorf 
Thermocycler „MyCycler“ Bio-Rad Laboratories 
Power supply „PowerPac“ Bio-Rad Laboratories 
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Type of device Manufacturer 
Mini-PROTEAN® 3 System Bio-Rad Laboratories 
Mini Trans-Blot® System Bio-Rad Laboratories 
Gel dryer „Gel Dryer Model 583“ Bio-Rad Laboratories 
pH-Meter „765 Calimatic“ Knick 
Microscope Olympus IX Confocal Micros. 
Photometer „Ultrospec 3000 pro“ Amersham Biosciences 
Pipette „Pipetman® Pipette Kit“ Gilson 
Pipette „Matrix CellMate® II“ Thermo Fischer Scientific 
Sonifier „Sonifier® S-250A“ Branson 
UV Stratalinker 1800 Stratagene 
ELISA-Reader „Multiscan MS“ Labsystems 
Inverting shaker „UltraRocker“ Bio-Rad Laboratories 
Film developer „Curix 60“ AGFA HealthCare 
Agarose gel chambers CTI GmbH 
Rotaion mixer „Test Tube Rotator“ (34528) Buddeberg GmbH 
Balance „CP2202S-OCE“ Sartorius 
Fine scale balance „TE124S-OCE“ Sartorius 
Water bath „Julabo UC“ Julabo 
Magnetic stirrer „IKAMAG® RCT“ IKA® Werke 
Neubauer chamber Marienfeld 
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5 Results 
5.1 A new potential interaction partner of HIPK2 
With the aim to gain novel insights into HIPK2 functions, a yeast two-hybrid screen in which 
the N-terminal part of HIPK2 containing the kinase domain was the bait has been performed 
and revealed a new potential interaction partner of the kinase. In this screen two 
independent fragments of a so far uncharacterized protein were fished and subsequent a 
full-length clone encoding for the concerned protein was cloned from cDNA libraries by 
coworker Ilka Dauth. The encoded protein is 1998 amino acids in size and has been termed 
SMC-hinge and MutL-homology domain (SMUDO) protein due to prominent structural 
homology to these factors, which were described in detail in the introduction (3.4, 3.5) 
(Losada&Hirano, 2005; Polosina&Cupples, 2010b). Overlapping of the two fished SMUDO 
fragments suggest that this region (118 aa) is part of a domain mediating interaction with 
HIPK2 (Fig. 3). 
 
 
Figure 3: Schematic overview on HIPK2 kinase and SMUDO protein. Fragments of these proteins which were 
used in the yeast-2-hybrid as bait or fished as prey screen, respectively, are shown. Numbers indicate consecutive 
amino acids. MutL domain (71 AA) of the SMC-hinge and MutL-homology domain (SMUDO) protein is marked by a red 
box, the SMC-hinge domain (154 AA) by a yellow one. 
 
Several open source software (ExPASy tools) were used to analyze the protein on the basis 
of its AA sequence A molecular weight of about 223 kDa was calculated for the SMUDO 
protein. Two conventional nuclear export signals (NES) and one nuclear localization signal 
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(NLS) were predicted inside the AA sequence. Beside this, a number of potential 
phosphorylation target motifs for HIPK2 (TP/SP sites) and also for ATM and ATR (SQ/TQ) 
were found. Additionally a couple of high potential SUMOylation sites were predicted by 
analysis software (Fig. 4A). 
 
 
Figure 4: Properties of SMUDO protein and results of software analysis based on its aa sequence. (A) Table 
listing result of software analysis. Exclusively open source software accessible via the ExPASy tools server was used 
for analysis and predictions. (B) Scheme of SMUDO protein indicating positions of potential HIPK2 phosphorylation 
sites (red lines), nuclear export signal (green line) and nuclear export signals (blue lines) inside the aa sequence. Red 
box: MutL domain. Yellow box: SMC-hinge domain. 
 
Hereafter it was decided to investigate the newly found protein more in detail, since its 
discovery as a potential HIPK2 interaction partner and its structural features, which refer to 
SMC and MutL protein classes which are involved in homologous recombination, mismatch 
repair and other DNA damage repair mechanisms, created a promising and attractive 
starting situation to get novel insight into the functions of HIPK2 and the mechanisms of 
DNA damage response in general (Losada&Hirano, 2005; Polosina&Cupples, 2010b). 
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5.2 SMUDO mRNA is ubiquitously expressed in human tissues 
To check whether SMUDO is regularly expressed in human cells, reverse transcription 
polymerase chain reaction (RT-PCR) was applied to detect SMUDO mRNA. For this RNA was 
prepared out of human cell lines derived from different tissues. SMUDO mRNA expression 
could be detected in all tested cell lines (Fig. 5A).  
 
Figure 5: SMUDO mRNA expression. (A) RT-PCR using human cell lines of several different origins. HepG2, 
Hep3Bliver carcinoma; U2OSosteosarcoma; GM03419primary fibroblasts; H1299lung carcinoma.  Actin 
mRNA was used as loading control. (B) Northern blot analysis of several human tissues. At least three different 
isoforms of SMUDO mRNA are indicated by arrows, one additional and very small potential isoform is indicated by an 
arrow set in brackets. Actin mRNA was used as loading control. (C) Sketch pointing out binding position of the DNA-
probe used for northern blot. Experiments performed by Ilka Dauth. 
 
 At least three different isoforms of SMUDO mRNA could be detected and in every single 
examined human tissue sample at the minimum one isoform was found. These results prove 
a ubiquitous expression of mRNA in diverse human tissues and strongly suggest the 
presence of SMUDO protein in those tissues. 
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After Blewitt et al. had reported on the SMUDO mouse paralog SmcHD1, expression of three 
isoforms of the human protein has been stated on the UniProtKB protein knowledgebase 
(Blewitt et al, 2008). The new information about the paralog in mice has been connected 
with preexisting and also with new data from different sources such as large scale 
screenings to identify the protein isoforms and to match them with the human 
SMUDO/SMCHD1 (www.uniprot.org; accession: A6NHR9). The longest isoform consists of 
2005 amino acids and exhibits seven additional amino acids at the C-terminus compared to 
the SMUDO construct used in this study. This isoform has been classed as the canonical one. 
The two smaller isoforms display splice variants with a length of 1917 and 762 amino acids, 
respectively, and have not been validated on the protein level so far. Overall, the data fit to 
the results of the Northern blot experiment shown above (Fig. 5B), which revealed three 
SMUDO mRNA isoforms (excluding the very small potential isoform), where two isoforms 
are similar in size and one is markedly smaller.  
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5.3 HIPK2-SMUDO interaction 
Since SMUDO was found in a yeast-2-hybrid screen as a possible interaction partner of 
HIPK2, attempts were made to investigate HIPK2-SMUDO interaction. To examine 
interaction in vitro, GST pull-down experiments were performed. For this purpose an 
expression vector suitable for in vitro translation and coding for a C-terminal fragment of 
SMUDO protein (SMUDOΔN) was produced. Radioactive labeled SMUDOΔN was generated 
by in vitro translation and a prokaryotic expression vector was used for preparation of GST-
tagged HIPK2 fragment (GST-HIPK2ΔC) matching the part of HIPK2 that was used for the 
initial yeast-2-hybrid screen (see section 5.1).  
 
 
Figure 6: SMUDO-HIPK2 in vitro interaction. (A) GST pull-down experiment. Signal in GST-HIPK2ΔC lane of the 
autoradiogram displays interaction of SMUDOΔN and the used GST-tagged fragment of HIPK2. Coomassie stain was 
used to check protein loading and GST protein as negative control for the pull-down. Experiment by Ilka Dauth. (B) 
Sketch indicating the parts of HIPK2 and SMUDO used for the pull-down experiment. 
 
GST protein was used as negative control and protein loading was checked by coomassie 
staining. On the autoradiogram a weak but clear signal was detectable (6A, last lane) 
confirming interaction between the used fragments of SMUDO and HIPK2 under in vitro 
conditions.  
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Once in vitro interaction of HIPK2 and SMUDO was demonstrated experiments were made to 
prove in vivo interaction of the proteins. Neither co-immunoprecipitation experiments with 
endogenous or overexpressed proteins, respectively, nor immunofluorescence studies have 
been successful to do so. More SMUDO interaction studies are described in section 5.9. 
 
5.4 Generation of SMUDO specific antibodies 
For further studies on the SMUDO protein, suitable tools for protein detection were needed. 
No commercial anti-SMUDO antibodies had been available at the time, thus polyclonal 
antibodies were generated in rabbit.  
 
 
Figure 7: SMUDO specific antibodies detect overexpressed SMUDO protein. (A) Myc-SMUDO was overexpressed 
in HEK293T cells. Lysates were prepared and SMUDO was precipitated by means indicated antibodies. SMUDO 
protein was finally detected via Western blot system. Functionality of anti-SMUDO antibodies is exemplarily shown 
for αSM16A (IP+WB) and αSM17A (IP). About 1 mg lysate was used for each IP. 5% (~50 µg) lysate controls gave only 
very weak SMUDO signal. (B) Schematic view indicating the positions of the epitopes inside the SMUDO aa sequence 
the antibodies bind to. Four polyclonal antibodies directed against a synthesized 17-mer were named anti-
SMUDO17A-D (α-SM17A-D), another four directed against a 16-mer were named anti-SMUDO16 (α-SM16A-D). 
 
For this two different oligopeptides corresponding to segments of the amino acid sequence 
of SMUDO protein were synthesized and applied to the animals in order to stimulate 
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generation of antibodies directed against SMUDO. Blood serum was taken from the animals 
and antibodies were purified for usage. One 16-mer peptide and one 17-mer peptide were 
used for the procedure, thus four generated antibodies directed against the 16 amino acid 
peptide were named anti-SMUDO16A-D (α-SM16A-D) and, in the same way, four antibodies 
directed to the 17 oligopeptide were labeled anti-SMUDO17A-D (α-SM17A-D). 
Then, antibodies were tested for biochemical applications. First, capability of the antibodies 
to precipitate SMUDO overexpressed in mammalian cells and to detect the protein in a 
Western blot system was checked (Fig. 7A). 
Furthermore, the antibodies were tested for immunoprecipitation of endogenous SMUDO 
protein out of lysates of several mammalian cell lines. Control HEK293T cells were 
transfected with Myc-SMUDO expression vector. 
 
Figure 8: Antibodies detect endogenous SMUDO protein. Each time 1 mg cellular lysate of HEK293T, U2OS or 
H1299 cells was applied for endogenous IP using anti-SMUDO antibodies. HEK293T cells overexpressing Myc-SMUDO 
were used as positive control. To check specificity of antibody binding, normal rabbit IgGs were used. 10% (100 µg) 
lysate controls were applied. 
Finding of SMUDO signal in IP lanes as well as in lysate controls (Fig. 8) demonstrated ability 
of the generated SMUDO-directed antibodies to bind the protein in a specific manner and 
their use for immunoprecipitation approaches and protein detection via immunoblot. 
Furthermore it confirmed the data from RNA expression experiments which had indicated 
SMUDO protein expression in several different cell lines (section 5.2). 
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5.5 Establishing of a SMUDO knockdown system 
One of the aims of this study was to get a hint at SMUDO protein function by suppressing its 
functions and monitoring a possible phenotype in cultured cell lines. For this purpose and 
for further experiments the establishment of a working knockdown system was required. 
Thus, RNA interference (RNAi) was used to downregulate SMUDO protein expression in a 
post-transcriptional manner. SMUDO cDNA sequence was searched for sequences suitable 
for siRNA targeting and several siRNAs were synthesized at Qiagen. Different human cell 
lines were transfected with siRNA and after 24 and 48 hours RNA was prepared out of the 
cell lysates. Semiquantitative RT-PCR was done and SMUDO mRNA levels were compared 
with a luciferase siRNA control (Fig. 9A). As loading control actin mRNA was used. 
 
 
Figure 9: siRNA mediated SMUDO knockdown. (A) RT-PCR after SMUDO siRNA transfection of HEK293T. Several 
SMUDO siRNAs were tested. siRNA directed against luciferase mRNA was used as knockdown control and actin mRNA 
as loading control. Asterisks mark most efficient siRNAs. (B) Western blot analysis of SMUDO protein level upon 
siRNA transfection of HEK293T cells. Tubulin (and unspecific band) was used as loading control.  
 
All tested SMUDO siRNA proved effective and two were selected for testing knockdown 
efficiency at protein level. As shown in Fig. 9, panel B, level of SMUDO protein was 
significantly decreased upon SMUDO siRNA transfection of HEK293T cells. The decrease of 
the SMUDO protein level was approximately about 70-90% after 24 hours and still stable 
after 48 hours. Since knockdown by transient siRNA transfection worked well, the next step 
was to establish cellular systems exhibiting persistent SMUDO knockdown for long term 
experiments. SMUDO siRNA sequences were cloned into lentiviral shRNA expression vectors 
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(pGLenti constructs) which were used for virus production and subsequent transduction of 
several target cell lines. 
 
Figure 10. Lentiviral SMUDO knockdown and siRNA target sites. (A) Western blot analysis of HCT116 cell lysates 
after transduction with lentiviral SMUDO shRNA constructs. A lentiviral construct carrying luciferase shRNA sequence 
was used as knockdown control. Actin was used as loading control. Lentiviral constructs express GFP, which was used 
as control of transduction efficiency. (B) Sketch indicating the siRNA target sites within mRNA as well as antibody 
binding sites in the amino acid sequence of the three predicted SMUDO isoforms. siRNAs: siSMUDO1-3 (siSM1-3). (C) 
Background bands of three anti-SMUDO16 antibodies and one anti-SMUDO17 antibody in comparison. Apparently 
none of these antibodies detects the second or the third potential isoform of SMUDO. Prominent bands either are not 
affected by SMUDO knockdown or they are not recognized by antibodies which should detect another isoform, 
respectively. Lysate out of HCT116 cells was used for this Western blot approach. 
 
Cells transduced with described constructs showed an efficient reduction of SMUDO protein 
level for several weeks without additional selection and also displayed GFP expression 
suggesting stable integration of shRNA expressing constructs into host cell genomes (Fig. 
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10A). This system was established in HCT116 cells as well as in U2OS cells and provided a 
tool for experiments based on SMUDO protein knockdown. 
As shown in Figure 10B, the used siRNAs siSMUDO2 and siSMUDO3 target sequences within 
the mRNAs of SMUDO isoform one and two. The third siRNA, siSMUDO1 targets all three 
isoforms. Primarily, siSMUDO3 was used in experiments, since its efficiency was best in 
most cases. In addition, the α-SMUDO17 antibodies bind only to the first protein isoform 
(canonical full-length isoform), whereas the α-SMUDO16 antibodies recognize each of the 
three. Consequently, shSMUDO3 should affect the two bigger isoforms which are similar in 
size and knockdown of the second isoform should be detectable with the batch of α-
SMUDO16 antibodies. However, a band that runs beneath the primary SMUDO band and 
disappears subsequent to SMUDO knockdown could not be detected (Fig. 10A, C). The same 
was true for smaller bands which could have represented the third isoform. 
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5.6 SMUDO in the context of the DNA damage response 
SMUDO protein shares characteristics with SMC proteins and also with MutL proteins, two 
protein families that have been shown to be involved in DNA damage repair (Cortes-
Ledesma et al, 2007; Polosina&Cupples, 2010a). Additionally, within this study, SMUDO was 
found to be an interaction partner of HIPK2 in vitro and potentially in vivo, where HIPK2 
plays a role in governing DDR (Calzado et al, 2007; D'Orazi et al, 2002; Dauth et al, 2007; 
Hofmann et al, 2002). Together these clues prompted the author to investigate a possible 
role of SMUDO in cells response to DNA damage. The previously established SMUDO 
knockdown systems were used to look at changes in markers for DDR after genotoxic stress 
was applied. For this, either UV light or Adriamycin (doxorubicin) were utilized to cause 
DNA damage and provoke a cellular response.  
In view of the demonstrated SMUDO-HIPK2 in vitro interaction, p53 phosphorylation at 
Serine 46 (p53Ser46-P) as indicator for HIPK2 activity as well as HIPK2 levels were the 
most likely candidates to examine. p53 protein level was used as a general indicator for DNA 
damage.  
 
Figure 11: DDR in HCT116 SMUDO knockdown cells upon Adriamycin treatment. Adriamycin was applied to 
HCT116-shSMUDO cells and control cells. Cells were harvested at indicated time points and lysates were prepared 
and used for Western blot analysis. 
 
In total, the experiments demonstrated that a knockdown of SMUDO protein has no obvious 
influence on HIPK2 activity (Fig. 11). Comparison of p53Ser46-P levels of control cells and 
SMUDO knockdown cells showed no significant or reproducible change. The same 
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observation was made for HIPK2 levels under steady state conditions as well as upon DNA 
damage caused by UV (Fig. 12B) or Adriamycin (not shown). 
 
 
Figure 12: DDR in HCT116 SMUDO knockdown cells. (A). DDR in HCT116 SMUDO knockdown cells upon UV. 
HCT116-shSMUDO cells and control cells have been irradiated with UV-C at 40J/m2. Cells were harvested at indicated 
time points and lysates were prepared and applied for Western blot analysis. (B) DDR in U2OS SMUDO knockdown 
cells upon Adriamycin treatment. Adriamycin was applied to U2OS-shSMUDO cells and control cells. Cells were 
harvested at indicated time points and lysates were prepared and used for Western blot analysis. 
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Since no effect on HIPK2 was found, additional other markers well known for their function 
in DNA damage response were chosen to check influence of SMUDO knockdown on DDR 
pathways not directly connected to HIPK2. Histone H2AX phosphorylated at Ser139 (γ-
H2AX) displayed formation of DNA repair foci and phosphorylation of p53 at Ser15 reflected 
activity of Chk1, a central downstream kinase in the DDR. 
In some experiments alterations were noticed in p53-Ser15-P, γ-H2AX (Fig. 12A) or even in 
SMUDO levels (Fig. 11) but those were not reproducible and in other experiments of the 
same setting no changes or even contrary changes happened (Fig. 12B, 12A). This was true 
for both HCT116 and U2OS cells. Thus those alterations were considered to be changes 
raised by as yet unidentified factors like small differences in cell density or passage. 
 
 
Figure 13: Colony formation of HCT116 SMUDO knockdown cells upon DNA damage. Cells were plated onto 6cm 
dishes and one day after plating DNA damage has been applied by UV (A) or Adriamycin (B) at indicated dosages.  
Five days later living cells were stained with Crystal violet. (C) Western blot analysis of cells used in (A) and (B) 
demonstrating knockdown of SMUDO protein. 
 
The results indicate that knockdown of SMUDO has no significant effect on DDR pathways 
examined in these experiments. To see whether a SMUDO knockdown influences overall cell 
survival for reasons not evident from these experiments, colony formation assays were 
additionally performed. Assays were performed in HCT116 (Fig.13) as well as in U2OS cells 
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(not shown) and revealed no alteration in cell survival after SMUDO protein knockdown 
indicating that the protein is not required for the cellular response to the applied DNA 
damage. 
 
5.7 Knockdown of SMUDO does not influence the overall activity of 
TDG 
At the same time described experiments for SMUDO characterizations have been carried 
out, another attempt was made to obtain information suggesting potential SMUDO functions. 
For this a second yeast-2-hybrid screen, in which an N-terminal part of SMUDO was the bait, 
has been performed. In the screen three times fusion hybrids of the thymine DNA 
glycosylase (TDG) came up as a potential interaction partner of SMUDO. 
 
 
Figure 14: Colony formation of shSMUDO-cells upon 5-FU treatment. HCT116 shSMUDO-cells (A) and U2OS 
shSMUDO-cells (B) as well as control cells were seeded on 6-well plates one day prior application of 5-fluorouracil at 
indicated dosages. After five days cells were stained with crystal violet. (C) Western blots showing knockdown of 
SMUDO protein in cells used for the colony formation experiments. 
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TDG is a G/T mismatch DNA glycosylase in mammals that removes thymine parts of G/T 
mismatches by hydrolyzing the bond between the thymine nucleobase and the sugar-
phosphate backbone of DNA. It also possesses a lower activity for C/T and T/T mismatches. 
Furthermore TDG also acts as a uracil DNA glycosylase (UDG), which removes uracil species 
misincorporated into DNA or generated by deamination, and has been demonstrated to 
mediate cytotoxicity of 5-fluorouracil (5-FU), a pyrimidine analogue whose metabolites are 
incorporated into DNA and RNA (Cortazar et al, 2007; Kunz et al, 2009). Mouse and human 
cells deficient in TDG display a high resistance to 5-FU exposure compared to wild type cells, 
whereas heterozygous cells show an intermediate sensitivity (Kunz et al, 2009). This 
context was used in the following colony formation experiment. 
After involvement of SMUDO in DDR could not be determined in previous assays using UV or 
Adriamycin to apply DNA damage, experiments were performed to check possible influence 
of SMUDO protein on the UDG activity of TDG. As shown in Figure 14, SMUDO knockdown 
seems to have no effect on TDGs cytotoxicity mediating UDG activity, since cell viability was 
not altered in SMUDO knockdown cells. Whether one of TDGs other activities is affected is 
not apparent from this experiment, but it demonstrated that SMUDO knockdown does not 
influence TDGs overall activity. 
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5.8 SMUDO fragments are not phosphorylated in vitro by HIPK2 
With HIPK2 being an S/T directed kinase and demonstrated in vitro interaction of SMUDO 
and HIPK2 fragments (section 5.3), SMUDO might be a phosphorylation target of HIPK2 
(Sombroek&Hofmann, 2009). To investigate this possibility, in vitro phosphorylation assays 
have been performed. The SMUDO amino acid sequence contains eleven SP/TP sites which 
are the phosphorylation motifs of HIPK2. For the experiments, GST-tagged fragments of 
SMUDO protein as well as a His-HIPK2-Flag construct have been expressed in E.coli and 
purified. HIPK2 and each single SMUDO protein fragment were then used for a 
phosphorylation reaction which included [γ-32P]-ATP. 
 
 
Figure 15: In vitro phosphorylation assay. Recombinant GST-tagged SMUDO fragments, DAZAP wt and His-HIPK2-
Flag were used for an in vitro kinase reaction. Radioactive labeled ATP, [γ-32P]-ATP, was used to mark phosphorylated 
proteins. GST-DAZAP wt was used as positive control.  
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On the autoradiogram HIPK2 showed typical autophosphorylation signals at the height of 
the full-length protein at about 130 kDa (Fig. 15) and the positive control (GST-DAZAP wt) 
also indicated proper working kinase HIPK2 activity. However, SMUDO fragments displayed 
no phosphorylation signals, not even the aa1291-1998 fragment, which contains six SP/TP 
sites. The emerging band below 95 kDa in the last lane of Fig. 15, which could have been 
mistaken for a signal of phosphorylated SMUDO fragment, was revealed to be a result of 
HIPK autophosphorylation and a signal shadow caused by SMUDO protein fragment and was 
also seen in other experiments of the series. 
According to the results of this experiment HIPK2 does not phosphorylate any of SMUDOs 
SP/TP sites under given in vitro conditions. Whether there could be phosphorylation under 
different in vitro conditions or in vivo will be discussed later. 
 
5.9 The SMC-hinge domain mediates SMUDO autointeraction 
Since SMC proteins are known to form dimers via the SMC-hinge domain and SMUDO 
possessing such a domain, it was a consequent step to check SMUDO’s potential to make up 
homodimers (Losada&Hirano, 2005). 
 
 
Figure 16: SMUDO auto-interaction. HA-SMUDO and Flag-SMUDO have been overexpressed in HEK293T cells. Co-
immunoprecipitation has been performed using anti-Flag antibodies. HA-SMUDO signal was detectable in Flag-
SMUDO/HA-SMUDO co-expressing cells (last lane). GFP was used as transfection control. 
 
As shown in Figure 16 (last lane), HA-tagged SMUDO could be precipitated in presence of a 
Flag-tagged SMUDO construct in an anti-Flag immunoprecipitation. After SMUDO auto-
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interaction could be demonstrated using tagged full-length constructs, the next step was to 
use MutL- and SMC-deletion constructs of SMUDO to verify the role of the SMC hinge domain 
in mediating binding and to look at a possible contribution of the MutL domain. 
   
 
Figure 17: The SMC-hinge domain mediates binding between SMUDO proteins. Experiment resembles 
experiment shown in Fig. 16 but additionally SMC and MutL deletion constructs of GFP-SMUDO have been included. 
Missing the SMC hinge disables co-immunoprecipitation of SMUDO (last lane). The band above EGFP is a degradation 
product of GFP-tagged constructs. 
 
The results of this experiment clearly prove that the SMC-hinge domain of the SMUDO 
protein is capable and sufficient to mediate dimerization or multimerization, whereas the 
MutL domain seems to be insufficient to mediate binding (Fig. 17). SMUDO-SMUDO co-
immunoprecipitation protocol included a sonication procedure. Without this 
immunoprecipitation of SMUDO protein was difficult since almost always a smear appeared 
on Western blot after incubation with anti-SMUDO antibodies indicating association of the 
protein with chromatin or another insoluble fraction. DNase digestion prior precipitation 
did not solve the problem and using sonication is the only working method for SMUDO-
SMUDO co-immunoprecipitation so far. The interaction mediated by the SMC-hinge domains 
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of SMUDO seems to be strong enough to withstand sonication or to achieve reassembling 
afterwards. However, other potential interaction partner of SMUDO might have a less strong 
affinity to the protein and sonication could terminate interaction permanently. 
Unfortunately, neither SMUDO interaction with HIPK2 nor with any other tested protein, 
such as SMC proteins or TDG, could be demonstrated with the exception of SMUDO itself. 
For that reason alternative SMUDO interaction assays will be discussed. Several SMC 
proteins, which share related hinge domains with SMUDO, have been tested, but could not 
be precipitated in interaction assays under diverse conditions. Since dimerization of SMC 
proteins is restricted to form distinct heterodimers and not miscellaneous dimers with all 
proteins exhibiting a SMC hinge domain, SMUDO might not be able to form dimers with SMC 
proteins even though the proteins have a homolog hinge domain in common.  
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5.10 SMUDO protein is primarily localized in the nucleus 
One of the first experimental attempts to characterize SMUDO protein has been 
overexpression of GFP-tagged constructs in U2OS cells and following microscopic analysis. 
The most notable observation was that the major part of the protein population seems to 
accumulate in the nucleus, while a smaller fraction remains in cytoplasm (Fig. 18A). 
Furthermore, in many cases irregularly shaped dots were observed in the nuclei of 
transfected cells.  
 
 
Figure 18: Nuclear localization of SMUDO. (A) GFP-SMUDO has been overexpressed in U2OS cells and showed a 
primarily nuclear localization and partially formation of dot like structures inside the nucleus. Pictures were taken 
with a classical fluorescence microscope. (B) Cellular compartment fractions have been analyzed by Western blot. 
PARP was used as indicator the nuclear fraction and GAPDH for the cytosolic fraction. 
 
To validate the indication of a nuclear localization of SMUDO, cellular compartment fractions 
of non-transfected cells have been prepared for Western blot analysis. As shown in Fig.  18B, 
the strongest endogenous SMUDO signals appeared in the nuclear fractions. Total cell 
lysates displayed weaker signals and in cytoplasmic fractions the signal was undetectable. 
These results confirmed a primarily nuclear localization of SMUDO protein. 
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Figure 19: Localization of the different SMUDO constructs. GFP-tagged SMUDO constructs have been 
overexpressed in U2OS cells and fluorescence pictures have been taken with a confocal microscope (pinhole diameter: 
90 nm). Pictures display the predominant phenotypes caused by overexpression of the different constructs. GFP-
SMUDO-full-length: As shown before, predominantly nuclear localization and, in some cases, formation of irregularly 
shaped dots. GFP-SMUDOΔSMC: Similar phenotypes to full-length SMUDO, but no formation of nuclear dots have been 
observed. GFP-SMUDOΔMutL: Distribution has been reversed and protein was more concentrated in the cytosol. 
Images have been taken with a confocal microscope. 
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U2OS cells and other cells lines tested seemed to be affected by a kind of cytotoxic effect of 
ectopic SMUDO overexpression. A striking number of cells, whose remains showed strong 
GFP-SMUDO expression, died. In total the transfection efficiency was low which might also 
at least in part due to the large plasmid size. Since GFP-SMUDO expression could be detected 
on the Western blot level, it is to assume that low level GFP-SMUDO overexpression is not 
toxic and not detectable in fluorescence as well, whereas high overexpression makes a 
detectable signal and somehow mediates cytotoxicity. 
Once GFP-tagged SMUDO deletion constructs for the MutL and SMC hinge domain had been 
cloned, they have been expressed in U2OS cells and resulting phenotypes have been 
compared with cells expressing full-length GFP-SMUDO. GFP-SMUDOΔSMC expressing cells 
resembled the described GFP-SMUDO-full-length phenotype, with the difference of not 
forming dots inside the nucleus (Fig. 19). In case of the GFP-SMUDOΔMutL signal was 
stronger in the cytosolic compartment rather than in the nucleus (Fig. 19). Neither the single 
nuclear localization signal (NLS) nor the two nuclear export signals (NES) inside SMUDOs 
amino acid sequence had been compromised by deletion of the concerned domains. 
Nevertheless, absence of the MutL domain seems to alter the distribution of overexpressed 
SMUDO protein and suggest that this domain supports localization within the nucleus. The 
reason for the lack of nuclear dot formation is highly speculative since the dots could be a 
result of protein aggregation upon overexpression and MutL and SMC deletion constructs 
had shown a slightly lower expression level where still only few cells exhibited detectable 
signal. 
Since immunofluorescence experiments on endogenous SMUDO protein turned out to be 
difficult because of background staining produced by the anti-SMUDO antibodies, 
experiments on overexpressed tagged SMUDO had to be used for further localization and 
mobility studies. To gain further information on SMUDO behavior in living cells, GFP-tagged 
SMUDO was over expressed in U2OS cells which then were used for fluorescence recovery 
after photobleaching (FRAP) experiments. One set of experiments comprised nuclear point 
bleaches applied by a laser beam at 488 nm. The other set included bleaching of either the 
cytosolic compartment or the nucleus. In both cases pictures have been taken over a time 
course and subsequently analyzed to determine the rate of recovery. 
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Figure 20: SMUDO FRAP experiments. (A) Compartment bleach experiments. Whole compartments, namely either 
the nucleus or the cytosolic compartment, have been bleached. Intensity of fluorescence is given in relation to whole 
cell.  (B) Nuclear point bleach experiments. Laser emission of 488 nm was used to bleach GFP-SMUDO protein at a 
limited area inside the nucleus of U2OS cells. Intensity of fluorescence is given in relation to the whole nucleus. Curves 
start at different fluorescence levels because of fast recovery prior the first frame of documentation. (A)+(B) Pictures 
have been taken at indicated time points. TR50-100 = time for recovery of 50% of fluorescence level before bleaching. 
TR50-Rec = time for recovery of 50% of fluorescence level at end of measurement. GADD45 protein is known to 
shuttle between nucleus and cytoplasm and was used as control (Carrier et al, 1994; Kearsey et al, 1995). 
Experiments and analysis performed with support of Dr. Eva Krieghoff-Henning. 
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Analysis of the compartment bleach experiments (Fig. 20A) displayed a distinct recovery of 
GFP-SMUDO fluorescence in the bleached areas, indicating shuttling of the tagged protein 
between nucleus and cytosol at a rate substantially slower compared to the GADD45 control. 
This effect might be explained with a conclusion from the nuclear point bleach experiments 
which also showed a clear recovery for GFP-SMUDO, but in contrast to the GFP-GADD45 
control it plateaued clearly beneath 100% fluorescence (Fig. 20B) within the measurement 
time. Since fluorescence intensity of bleached points was evaluated in relation to the whole 
nuclei, this result suggests the existence of an immobile fraction of GFP-SMUDO that cannot 
quickly diffuse into a bleached area. Besides, no significant accumulation of GFP-SMUDO at 
the site of laser induced DNA damage has been documented over an imaging time of about 
three hours (not shown). 
Additional FRAP experiments including deletion constructs (Fig. 20B) revealed an increase 
of fluorescence recovery rate for SMC hinge deletion constructs upon nuclear point bleaches. 
For ΔMutL constructs the increase was even stronger and very close to the rate of the 
GADD45 control. In compartment FRAP experiments GFP-SMUDOΔSMC displayed a 
recovery rate similar to the full-length construct, GFP-SMUDOΔMutL in contrast showed an 
elevated rate at intermediate level between GFP-SMUDO-full-length and GADD45 control 
(Fig. 20A). Together the IF and FRAP data suggest that the MutL domain may anchor SMUDO 
at immobile structures within the nucleus, for instance on chromatin, whereas the SMC 
hinge domain only slightly affects SMUDO nuclear localization and mobility within the 
nucleus. 
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6 Discussion 
6.1 Discovery of an unknown protein 
HIPK2 functions as an important switching element in the cellular DNA damage response. 
Dependent on the extent of damage the kinase promotes apoptosis or induces growth arrest 
to prevent proliferation and heredity of corrupted genetic information (D'Orazi et al, 2002; 
Dauth et al, 2007; Di Stefano et al, 2005). Over the last years many studies concerning HIPK2 
were conducted, most of them focusing on HIPK2 regulation and its role in the induction of 
p53-dependent and p53-independent apoptosis. A number of interaction partners of HIPK2 
involved in DNA damage response or other processes have been found and investigated 
(Calzado et al, 2007; Puca et al, 2010; Rinaldo et al, 2007b; Sombroek&Hofmann, 2009). 
Within this thesis SMUDO, a novel HIPK interaction partner, which had been unknown at the 
beginning of the work, was studied and characterized. Initially SMUDO was found to be a 
potential binding partner of HIPK2 in a yeast two-hybrid screen. Two times overlapping 
parts of a not yet described protein came up as prey and based on these fragments a 
construct of the protein coding sequence could be cloned from cDNA libraries. 
Upon production of a full-length construct first software analyses based on the amino acid 
sequence have been performed and revealed some remarkable features of the protein. One 
characteristic of the protein is its size of almost two thousand amino acids and a calculated 
molecular weight of about 230kDa that exceeds even that of the large SMC proteins, such as 
the human SMC1A, which consists of 1233 amino acids and has a mass of 143 kDa 
(www.uniprot.org; accession: Q14683). 
Most importantly, the amino acid structure of SMUDO compromises two domains related to 
known protein classes. One domain shows homology with the mentioned SMC protein 
family, while the second domain seems to be related to the MutL proteins. Together the 
protein classes gave the reason to name the newly found protein SMC-hinge and MutL-
homology domain protein, SMUDO. The members of the SMC protein family are involved in 
diverse cellular functions, especially their roles in chromosome metabolism and DNA repair 
mechanisms are prominent and in the focus of research (Cortes-Ledesma et al, 2007; 
Losada&Hirano, 2005). MutL proteins are known for their participation in DNA mismatch 
repair as well as in mitotic and meiotic recombination (Polosina&Cupples, 2010a). The 
extent of homology to the referring protein classes differ between the MutL and the SMC-
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hinge domain. While the SMC-hinge domain is relatively highly homologous to SMC proteins, 
the MutL domain shows only a low homology to the MutL protein family (NCBI, Conserved 
Domains server). As a consequence it is very unlikely that the SMUDO MutL domain exhibits 
ATPase activity similar to the corresponding region of MutL proteins, since three of four 
motifs important for ATP binding which are stated in the literature (Ban&Yang, 1998; 
Guarne et al, 2001) are not conserved.   
Additionally, two classical nuclear export signals, a classical nuclear localization signal, a 
couple of potential HIPK2 phosphorylation motifs, several ATM/ATM phosphorylation 
motifs and more than ten high potential SUMOylation sites have been found in the primary 
protein structure. 
It was decided to investigate the unknown SMUDO protein and its potential connection to 
HIPK2 more in detail, where the circumstances of its discovery and its structural features 
predetermined the focus of work to be on DNA damage response. 
First, SMUDO mRNA expression in several human cell lines of different backgrounds as well 
as in different human tissues was checked and verified. All tested cell lines showed SMUDO 
mRNA expression in semi-quantitative RT-PCR and at least one isoforms of SMUDO mRNA 
could be detected in every single tissue analyzed by Northern blot (chapter 5.2). These 
results strongly suggest the ubiquitously expression of SMUDO protein in human tissues and 
functions that are not tissue restricted. 
The UniProtKB protein knowledge base lists three potential protein isoforms for the human 
SMUDO/SMCHD1 protein. The first and longest one is 2005 amino acids in size, the second 
displays a length of 1917 amino acids and the third consists of 726 amino acids 
(www.uniprot.org; accession: A6NHR9). Only the longest isoform has been confirmed on 
protein level so far and has been stated to be the canonical one. Besides of seven additional 
amino acids at the C-terminus, this isoform resembles the SMUDO-full-length construct 
which was used within this thesis. In addition, the ratios of the isoforms stated at the 
UniProtKB database match the mRNA isoforms found in the Northern blot experiment: The 
biggest and the second biggest isoform are similar in size, while the third isoform is 
distinctly smaller.  
Consisting of 2005 amino acids the first protein isoform has to be translated from an mRNA 
with a coding region of 6015 base pairs followed by a stop codon. However, the largest 
mRNA isoform found in the Northern blot experiment is approximately 8-9 kilobases in size 
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which can be explained by the untranslated regions contained in eukaryotic mRNA, namely 
the 5’ untranslated region (5’-UTR), the 3’ untranslated region (3’-UTR) and the poly-A tail.  
It has to take into account that only the first isoform has been confirmed at protein level 
whereas the other two isoform are predictions primarily based on large scale RNA 
screenings. Whether these isoforms exist on protein level remains unclear, even in the 
experiments presented in this work no confirmation of their existence was given. Neither 
comparisons of SMUDO Western blot signals of knockdown cells and control cells nor the 
usage of different anti-SMUDO antibodies revealed any hints for smaller protein isoforms 
(5.5). One possible explanation may be protein expression on a very low level undetectable 
in the used assays. Whether such a small amount of an isoforms could accomplish a 
biological task by itself is not clear, but cooperation with the attested canonical protein 
isoform is imaginable. Regulatory mechanisms might be another explanation for the 
existence of additional SMUDO mRNA isoforms. Several of such RNA silencing mechanisms 
in plants, animals or other eukaryotes are known, but so far only RNAs significant smaller 
than the SMUDO isoforms have been shown to be involved (Heard&Colot, 2008; Kanno et al, 
2008; Ng et al, 2007). 
At the same time first examinations were made, production of tools for further 
investigations of SMUDO was started. Most important was the production of SMUDO specific 
antibodies, since antibodies working for Western blot detection were essential perquisite 
for this study and no commercial antibody had been available at that time. Thus a number of 
polyclonal antibodies, directed against either a 16 peptide or a 17 peptide of the SMUDO 
amino acid sequence, were generated in rabbit. The value of the antibodies for protein 
detection in Western Blot as well as for immunoprecipitation of overexpressed or 
endogenous SMUDO protein has been validated (section 5.4). Several of these antibodies 
generated clear SMUDO signals in Western blot analysis which have been confirmed by 
SMUDO protein knockdown (see below). Usually the same antibodies adequate for Western 
blot were also suitable for immunoprecipitation of SMUDO. Since the antibodies were 
generated against peptides this might be a clue for a structure of the areas containing the 
epitopes that is not in a coiled or a compact form what would likely prevent epitope 
recognition. Immunofluorescence studies have also been conducted, but the outcomes 
showed far too much background staining at endogenous protein so far. Another aim this 
study was the establishment of a SMUDO knockdown system to study the effect of a reduced 
SMUDO level on cellular phenotypes and on markers of the DNA damage response.  
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6.2 SMUDO in the DNA damage response 
As mentioned before, by the time first characterizations had been made on SMUDO protein 
it has been decided to focus on its potential involvement in DNA damage response. Several 
facts pointed towards this field as a promising candidate for a cellular system SMUDO is a 
component of. First, the protein was found in a yeast two-hybrid screen in which a part of 
HIPK2 was the bait, therefore being a potential interaction partner of the kinase that is 
known for its role in mediating and integrating the cells response upon genotoxic stress. 
Second, the most prominent structural features of the protein refer to two different protein 
classes which have one thing in common, their participation in DNA repair. A third 
indication was given by an additional yeast two-hybrid screen. This time a part of SMUDO 
was used as bait and a protein was fished which is also involved in DNA repair, the thymine-
DNA glycosylase (TDG). Together these hints were convincing to concentrate investigations 
onto DNA damage response. 
At first it was checked whether SMUDO protein level is changed upon several kinds of DNA 
damage, but no alterations have been observed (not shown). It was decided to develop a 
SMUDO knockdown system (section 5.5) to examine possible effects on the DNA damage 
response using several protein markers as indicators for activated DNA damage signaling. 
DNA damage has been applied by several means but primarily by UV radiation or 
Adriamycin (doxorubicin), because these agents are known to activate HIPK2.  
One obvious question was if a decrease in SMUDO protein level would influence HIPK2 level 
and/or activity, since a basic idea of this thesis is a potential interaction between SMUDO 
and HIPK2 in the context of the DNA damage response. For this, HIPK2 levels of SMUDO 
knockdown cells and control cells have been compared. As an indicator for HIPK2 activity 
p53 protein phosphorylated at serine residue 46 (p53Ser46-P) has been used. 
The corresponding experiments revealed no significant alterations in HIPK2 levels under 
steady state conditions as well as upon applied DNA damage. A similar observation was 
made for p53Ser46-P levels indicating an unchanged HIPK2 activity in case of SMUDO 
knockdown (Fig. 11, 12A). 
Additional markers were analyzed to investigate the effect of SMUDO knockdown on DNA 
damage response independent of HIPK2. Phosphorylation of Histone H2AX at Ser139 (γ-
H2AX) suggested formation of DNA repair foci and p53 phosphorylated at Ser15 reflected 
activity of Chk1, a central downstream kinase in the DNA damage response. Like in the case 
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of HIPK2 no noticeable and reproducible changes could be observed in SMUDO knockdown 
cells compared to control cells (Fig. 11, 12). 
Some experiments showed variations in γ-H2AX, p32-Ser15-P (Fig. 12A) or even in SMUDO 
levels (Fig. 11), but overall they were proven to be not reproducible. Accordingly, these 
alterations were considered to be results of factors like small differences in the density of a 
cell population or in its passage counts and not to be provoked by the SMUDO knockdown. 
Upon obtaining no hints for an influence of SMUDO knockdown on the examined DNA 
damage response factors, colony formation assays were performed to check the overall cell 
survival since possible effects on the cellular response upon genotoxic stress may not have 
been detectable in the former experiments. Compared to control cells the SMUDO 
knockdown cells displayed no decrease in cell growth at any extent of applied DNA damage 
(Fig. 13). 
A further attempt to gain information that could give a lead to possible SMUDO functions in 
the DNA damage response based on the outcome of a yeast two-hybrid screen already 
mentioned in which a part of SMUDO was the bait. In this screen the thymine-DNA 
glycosylase (TDG) was found to be a potential interaction partner of SMUDO. This enzyme 
possesses a G/T mismatch DNA glycosylase activity, with an additional low affinity for C/T 
and T/T mismatches, as well as a uracil DNA glycosylase (UDG) activity which removes 
uracil species misincorporated into DNA or generated by deamination. The uracil DNA 
glycosylase activity has been shown to mediate cytotoxicity of the chemotherapeutic 5-
fluorouracil (5-FU), metabolites of the pyrimidine analogue are incorporated into DNA and 
RNA where they cause genotoxic stress. Human as well as mouse cells deficient in TDG 
exhibit a strongly increased resistance to 5-FU exposure and heterozygous cells display 
intermediate sensitivity to the drug. 
According to this an influence of SMUDO knockdown on TDG activity and the cytotoxic effect 
of 5-FU has been tested. In case of SMUDO being involved in the uracil DNA glycosylase 
function of TDG, a change in the impact of 5-FU exposure on SMUDO knockdown cells 
compared to control cells should have been the consequence. Colony formation assays have 
been performed and indicated that a knockdown of SMUDO has no effect on the uracil DNA 
activity of TDG. No changes in cell viability could be observed (14). 
Furthermore, no GFP-SMUDO accumulation at the site of UV-laser applied DNA damage has 
been observed within a period of three hours, when tested in context of FRAP experiments 
(not shown). Taken together, no indications for an effect of a SMUDO knockdown on the 
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examined DNA damage pathways have been found. The crucial point to mainly use these 
agents was their known activating effect on HIPK2, the kinase that had appeared to interact 
in vitro with SMUDO and possibly cooperates with the protein in vivo. Since the efficiency of 
the SMUDO knockdown proved to be very high it seems to be unlikely that the performed 
experiments could not demonstrate SMUDO involvement in DNA damage response because 
of too much protein remaining in the cells. 
Participation of SMUDO in other pathways of the DNA damage response triggered by 
different kinds of genotoxic stress remains to be unclear and is point to be checked in 
further studies about SMUDO. Many types of DNA damage and the responsible repair 
pathways have been covered in the performed experiments. In most of the referring 
experiments DNA damage has been applied by UV or Adriamycin (doxorubicin), but also by 
5-fluorouracil, agents causing the formation of bulky adducts, replication fork stalling, 
single-strand damage, double strand breaks and U/G mismatches.  
Several types of base mismatches, G/T, T/T or C/T mismatches for instance, remain to be 
investigated in respect of TDG and the DNA mismatch repair in general. Direct lesion 
reversal of alkylated bases such as 6-O-methylguanine or the repair of DNA lesions like 8-
oxoguanine caused by reactive oxygen species could also be investigated. Hydrolytic 
chemicals (for G/T mismatches), alkalyting agents such as ethylnitrosurea (for 6-O-
methylguanine) or oxidative chemicals (for 8-oxoguanine) could be used to generate the 
corresponding kind of DNA damage for colony formation assays similar to these shown in 
this work which were used to examine a potential effect of a strongly reduction in SMUDO 
level. 
Despite the found connection to HIPK2, SMUDO could be part of DNA damage pathways the 
kinase is not involved in or its involvement is not known yet. Moreover, cooperation is also 
possible in HIPK2 pathways apart from DNA damage repair and will be discussed in the last 
chapter.  
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6.3 SMUDO interactions and alternative functions 
Besides fundamentally characterizing SMUDO, in the course of this thesis potential functions 
of the protein were supposed to be identified. In part this was done by protein interaction 
assays. Given that the SMUDO project started with a yeast two-hybrid screen suggesting an 
interaction with HIPK2, a part of the experiments were dedicated to pursue this link. In the 
first instance in vitro interaction of the two proteins was to be verified. Next, in vivo 
interaction was to be investigated. 
The investigations started with pulldown experiments which confirmed the in vitro 
interaction of SMUDO and HIPK2 fragments indicated by the initial yeast two-hybrid screen. 
A GST-tagged HIPK2 construct matching the same part of the kinase that had been used for 
yeast two-hybrid screen showed binding to a radioactive labeled SMUDOΔN construct (5.3, 
Fig.6). Subsequent studies addressing in vivo interaction of the proteins were started. 
Immunoprecipitation experiments with overexpressed as well as with endogenous HIPK2 
and SMUDO protein were performed under various conditions, but could not demonstrate 
HIPK2-SMUDO binding. Mammalian two-hybrid system might be used to proceed with 
HIPK2-SMUDO interaction studies, since protein binding in mammalian cells better mimics 
in vivo protein interaction and the system might even allow usage of full-length constructs. 
Furthermore, in vitro assays concerning phosphorylation of SMUDO by HIPK2 could not 
confirm a functional cooperation of the proteins. This might be due to the usage of SMUDO 
fragments recombinantly expressed in bacteria without eukaryotic post-translational 
modifications. GST-protein expression in yeast could improve experimental conditions by 
allowing those modifications. 
Other proteins than HIPK2 were also candidates for SMUDO interaction studies. Especially 
SMUDO itself was predestinated for autointeraction testing due to the fact that dimerization 
via SMC-hinge domains is well known from the SMC protein family. Two differently tagged 
SMUDO constructs were used for co-immunoprecipitation assays which showed that 
SMUDO autointeraction occurs indeed (section 5.9, Fig. 16). In further experiments the role 
of SMUDO’s SMC hinge domain in mediating the interaction has been examined, because 
binding between SMUDO proteins could have be achieved by the remaining parts of its 
structure, like the MutL domain.  
GFP-SMUDO constructs either lacking the SMC hinge domain or the MutL domain have been 
used together with a Flag-tagged full-length construct for regarding tests. In the absence of 
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the MutL domain the concerning construct could still be co-precipitated, whereas the 
construct lacking the SMC hinge domain was lost (5.9, Fig. 17).  
These results clearly demonstrated that the SMC-hinge domain contained in the SMUDO 
amino acid structure is capable and essential for mediating binding between SMUDO 
proteins under the given experimental conditions. Concurrent the MutL domain has been 
proved to be insufficient to mediate binding. In view of the SMC protein family, whose 
members form heterodimers, it is likely that SMUDO proteins act similarly and also make up 
dimers in vivo. In this case they would be homodimers. However, other ways for linking 
SMUDO proteins different from the SMC protein mechanism are not very likely but still 
possible (Fig. 21). One or more unknown factors could be required for mediating 
dimerization or even multimerization of SMUDO. And, of course, multimerization could also 
occur without an additional mediator. To test this pulldown assays could be performed 
using recombinant expressed SMUDO fragments containing the SMC-hinge domain. One 
fragment would be tagged by GST, a second one by a different tag what allows detection and 
differentiation after pulldown. 
 
 
Figure 21: Models for SMUDO-SMUDO interaction. Binding could be directly achieved by the SMC hinge domain or 
mediated by an unknown factor. Formation of dimers as well as of complexes consisting of more than two SMUDO 
proteins is conceivable. In consideration of mechanisms known from SMC proteins, direct formation of dimers is the 
most likely option. The spatial structural of the protein is unknown and areas others than the SMC-hinge and MutL 
domain have been illustrated as curved arms due to impressions from SMC complexes (Losada&Hirano, 2005).  
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In addition to HIPK2 and SMUDO a couple of other proteins have been tested in co- 
immunoprecipitation assays for interaction with SMUDO. The thymine DNA glycosylase 
(TDG) and several SMC proteins had been other obvious candidates, since they were found 
in yeast two-hybrid screen as a potential SMUDO interaction partner or share a related 
hinge domain, respectively. Similar to the previously described HIPK2-SMUDO interaction 
experiments none of these proteins was found to bind to SMUDO. 
The tested proteins may not interact with SMUDO, but another reason could be 
inappropriate experimental protocols. Early on, SMUDO immunoprecipitation assays had 
proven to be difficult.  When lysis buffer containing mild detergents that spare the nuclear 
membrane were used, the yield of SMUDO protein was very low. Later immunofluorescence 
studies showed a primarily nuclear localization of the protein, thus only a small cytosolic 
fraction was extracted from cellular lysates. Buffers breaking down nuclear membranes 
provided increased yield, but smear disturbed SMUDO signal on Western blot after 
incubation with anti-SMUDO antibodies, suggesting the association of the protein with an 
insoluble fraction like chromatin. Efforts to solve this problem by DNase digestion prior 
precipitation or usage of alternative buffers have not been successful. So far, sonication of 
cellular lysates is the only working method found to make at least SMUDO-SMUDO co-
immunoprecipitation possible.  
It has been demonstrated that the SMC-hinge domain mediates interaction between SMUDO 
proteins. Their affinity seems to be strong enough not to be dissolved by sonication or to 
accomplish reassembling after dissolution. The other tested proteins might have a lower 
affinity to SMUDO in a way that a potential interaction is permanently destroyed by the 
sonication procedure. For further interaction studies intermolecular crosslinking could be 
integrated into precipitation protocols to stabilize fragile bonds between SMUDO and other 
proteins before sonication is applied. Crosslinking SMUDO to binding partners and 
subsequent immunoprecipitation followed by SDS-PAGE and Western blot analysis could be 
used to detect suspected proteins. Additionally, it would be possible to cut bands of proteins 
crosslinked and co-precipitated with SMUDO out of the blotting membrane for analysis by 
mass spectrometry. This method would allow identifying new proteins which interact with 
SMUDO in a transient or stable way. 
Another strategy to investigate SMUDO protein and its interactions was to use fluorescence 
as well as immunofluorescence microscopy techniques. One goal was to overexpress tagged 
SMUDO protein together with a potential binding partner, HIPK2 for instance, and to 
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analyze intracellular localization of the proteins particularly with regard to co-localization. 
Further experiments should have included immunostaining of endogenous proteins to 
validate possible findings. Unfortunately two big problems emerged in the context of these 
studies. 
First, a part of the cells in which SMUDO was overexpressed to high levels suffered a sort of 
cytotoxic effect, especially when HIPK2 was co-expressed. Together with very low 
transfection efficiency this was the reason why co-expression experiments and subsequent 
microscopic analysis could not be performed. Since SMUDO overexpression was frequently 
applied in other experiments and signal of ectopic SMUDO could be detected in Western 
blot, low level overexpression is apparently not toxic but also not detectable in fluorescence 
as well. 
Second, the generated anti-SMUDO antibodies have been tested for immunofluorescence 
applications, but proved to produce a high amount of cellular background signal which 
prevented their usage in experiments involving the staining of endogenous SMUDO protein. 
Thus, microscopy examinations were restricted to tagged SMUDO overexpressed in the few 
cells that had not died by the treatment.  
When GFP-SMUDO overexpressing cells were observed under a microscope, the dominant 
phenotypes suggested a predominantly nuclear localization of the protein (chapter 5.10, Fig. 
18), thereby strengthening the indications from co-immunoprecipitation assays. To confirm 
a primarily nuclear localization of SMUDO cellular fractions were prepared and analyzed by 
Western blot. The results demonstrated that the biggest fraction of endogenous SMUDO is 
indeed localized in nucleus of a cell, while only a minor fraction remains inside the cytosolic 
compartment (5.10, Fig. 19).  
Most observed cells expressing tagged SMUDO full-length (GFP-SMUDO-fl) construct 
displayed a pan-nuclear staining often manifold stronger than the signal from the cytosol. 
Moreover, many of these cells showed formation of irregular shaped dots inside the nucleus 
(section 5.10, Fig. 18). This could be due to regular localization of SMUDO protein and might 
be cell cycle dependent or due to an artificial protein aggregation caused by overexpression. 
Deletion constructs lacking either the SMC-hinge domain (GFP-SMUDOΔSMC) or the MutL 
domain (GFP-SMUDOΔMutL) have been cloned and expressed in cells to compare the 
resulting phenotypes with cells expressing the full-length construct. In case of 
overexpressing GFP-SMUDOΔSMC the phenotypes was similar to that of full-length SMUDO 
featuring a higher protein concentration in the nucleus than in the cytosol (Fig. 19). 
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Nevertheless, one remarkable difference was observed, since dot formation did not occur in 
even one examined cell, which could imply that the SMC-hinge domain might be responsible 
for SMUDO recruitment to the dots or protein aggregation. 
When the GFP-SMUDOΔMutL construct was overexpressed, the distribution of SMUDO 
protein was changed. Fluorescence signal was now stronger in the cytosolic compartment 
and distinctly weaker in the nucleus (Fig. 19). By deleting the MutL or the SMC-hinge 
domain, neither the predicted nuclear export signals nor the nuclear localization signal had 
been destroyed, suggesting that the domains themselves cause the described phenotypes. 
Fluorescence recovery after photobleaching (FRAP) techniques were used to gather more 
information about SMUDO localization and mobility. In one series of experiments either the 
nucleus or the cytosolic compartment of cells expressing different GFP-SMUDO constructs 
was bleached by a laser beam to measure the rate of fluorescence over time.  
Upon bleaching the concerned compartments, recovery of GFP-SMUDO fluorescence 
suggested that the protein shuttles between cytosol and nucleus (section 5.10, Fig. 20A). The 
rate of recovery was substantially lower compared to the used control. In a second 
experimental series, in which a restricted nuclear area had been bleached (nuclear point 
bleach), GFP-SMUDO-fl signal recovered, but in contrast to the control it reached a plateau 
clear beneath 100% fluorescence (Fig. 20B). Taken together these results give a hint to the 
existence of an immobile GFP-SMUDO fraction which is not able to diffuse quickly into 
bleached areas.  
GFP-SMUDOΔSMC displayed a recovery rate similar to that of GFP-SMUDO-fl upon 
compartment bleach, whereas the MutL deletion construct displayed a distinctly elevated 
recovery rate (Fig. 20A). In nuclear point bleach FRAP experiments GFP-SMUDOΔSMC 
showed a higher recovery rate compared to full-length GFP-SMUDO. GFP-SMUDOΔMutL 
displayed an even faster recovery that was almost as fast as the used control (Fig. 20B). 
Considering all data from immunofluorescence microscopy studies and FRAP experiments, 
the MutL domain might be responsible for the nuclear localization of SMUDO and act as an 
anchor to the immobile phase of the nucleus such as chromatin. The SMC-hinge domain in 
contrast seems to influence only SMUDO mobility and localization within the nucleus to 
some extent by supporting the binding to the immobile phase (Fig. 22).  
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Figure 22: Impact of SMUDO domains on protein localization. SMUDO is primarily nuclear localized and likely 
binds to chromatin in an unknown way. The MutL domain seems to be required for SMUDO localization into the 
nucleus. In its absence most protein is present in the cytosolic compartment and its mobility within the nucleus is 
remarkably increased. The SMC-hinge domain supports binding to the immobile nuclear fraction. 
 
The possibility of SMUDO binding to DNA or chromatin should be investigated in further 
experiments, since hinge domains of dimerized SMC proteins are known to directly interact 
with chromatin (Chiu et al, 2004). In addition, the region of MutL protein related to the 
SMUDO MutL domain also binds DNA, where it has to take into account that the homology is 
rather low (Polosina&Cupples, 2010b). The idea of chromatin binding is also supported by 
data from a study on SmcHD1, a SMUDO mouse ortholog, in which the protein is shown to 
localize to inactivated X chromosomes (Blewitt et al, 2008). This work also shows that 
SmcHD1 is important for the maintenance of X inactivation and the hypermethylation of CpG 
islands in the course of X inactivation in female mice, where some of the hypermethylated 
genes are upregulated in knockout mice. Together with the hints found during this thesis, 
chromatin binding of SMUDO seems to be very likely. 
Since no indications were given for an involvement of SMUDO in the DNA damage response, 
a role in epigenetic regulation similar to that of SmcHD1, and a possible involvement of 
HIPK2 in these processes might be promising to explore. SMC proteins are known to 
participate in dosage compensation in C.elegans XX hermaphrodites, mammalian condensin 
interacts with Dnmt3b and mammalian cohesin associates with Snf2h, a chromatin 
remodeling enzyme (Geiman et al, 2004; Hakimi et al, 2002; Lieb et al, 1996). Thus, 
examples for a function of mammalian SMC complexes in epigenetic regulation exist in the 
literature, although the number of studies in this context is small compared to studies about 
SMC protein involvement in the DDR and chromatin remodeling during regular meiosis and 
 ____________________________________________________________________________________________ Discussion 
86 
 
mitosis. The same is true for HIPK2, since some studies suggest a role of the kinase in 
epigenetic processes, for instance by modulating and regulating the methylation-dependent 
transcriptional repressors ZBTB4 or MeCP2 (Bracaglia et al, 2009; Yamada et al, 2009). 
Therefore, the chance is given that the function of SMUDO and its connection to HIPK2 is to 
be found within the field of epigenetic rather than in DNA damage response. However, a 
function restricted to X dosage compensation is unlikely since SMUDO has been found to be 
expressed in several male cell lines (e.g. HCT116, HepG2). 
Gel mobility shift experiments should be performed for first general analysis of a potential 
SMUDO-DNA interaction. In case of confirmed binding ChIP-on-chip assays or ChIP-
sequencing could be used to map the binding sites of the protein and to obtain indications 
for the functional relevance of the protein-DNA interaction. 
In the course of this work, it could be shown that SMUDO is a primarily nuclear localized 
protein which likely forms homodimers via its SMC-hinge domain and binds to chromatin 
through its MutL domain. Although hints were given, an involvement of SMUDO in the DNA 
damage response, its interaction with TDG or HIPK2 in living cells and a possible impact of 
SMUDO on cell survival could not be demonstrated. Hence, alternative pathways of the DNA 
damage response should be investigated. Additionally, a putative connection of SMUDO and 
HIPK2 in epigenetic silencing presents another interesting direction of research that should 
be followed.  
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7 List of Abbreviations 
293T   human embryonic kidney 293T cells (HEK293T) 
5-FU   5-fluorouracil 
53BP1   p53-binding protein 1 
γ-H2AX  histone H2AX phosphorylated at Ser139 
µg   microgram 
AB   antibody 
AID   auto inhibitory domain 
AML1   acute myeloid leukemia 1 
Amp   ampicillin 
Asp   aspartic acid 
ATM   ataxia-telangiectasia mutated 
ATP   adenosine triphosphate 
ATR   ataxia-telangiectasia and Rad3 related 
ATRIP   ATR interacting protein 
BER   base excision repair 
BsSMC   Bacillus subtilis SMC 
bp   base pair 
BP   basic patch 
BSA   bovine serum albumin 
C/T   cytosine/thymine mismatch 
CBP   CREB Binding Protein 
CDC25   cell division cycle 25 
cDNA   complementary DNA  
CDS   coding sequence 
ChIP   chromatin immunoprecipitation 
CHK1   checkpoint kinase 1 
CHK2   checkpoint kinase 2 
CIP   calf intestine phosphatase 
CtBP   C-terminal binding protein 
CTD   C-terminal domain 
DAZAP  deleted in azoospermia associated protein 
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DDR   DNA damage response 
DMEM   Dulbecco`s modified Eagle`s medium 
DMS3   defective in meristem silencing 3 
DMSO   dimethylsulfoxid 
DNA   desoxyribonucleic acid  
DNA-PK  DNA proteinkinase 
dNTP   deoxyribonucleotide phosphate 
DSB   DNA-double strand break 
dsDNA   double stranded DNA 
DTT   dithiotreitol 
E. coli   Escherichia coli 
EDTA   ethylendiamintetraacetic acid  
EGFP   enhanced green fluorescent protein 
EGTA    ethylene glycol tetraacetic acid 
et al.   und andere (et alii) 
FCS   fetal calf serum 
Fig.   figure 
FISH   fluorescence in situ hybridization 
For   forward  
FRAP   fluorescence recovery after photo bleaching 
G/T   guanine/thymine mismatch 
Gadd45  frowth arrest and DNA damage inducible protein 45 
Gal3   galectin 3  
GAPDH  glyceraldehyde 3-phosphate dehydrogenase 
GFP   green fluorescent protein 
GST   glutathion-S-transferase 
h   hour(s) 
H2AX   histone H2AX 
H3K27me3  histone H3 trimethylated at Lysine 27 
HA   hemagglutinin 
HCl   hydrogen chloride 
HBS   HEPES buffered saline 
HDM2   Human Homolog of MDM2 
HEK293T  human embryonic kidney 293T cells 
 ________________________________________________________________________________ List of Abbreviations 
89 
 
HEPES   4-(2-hydroxyethyl)-1-piperazineethanesulfoni acid 
HID   homeoprotein interaction domain 
HIPK2   homeodomain interacting protein kinase 2 
HMGA1  high mobility group AT-hook 1 
HNPCC  hereditary nonpolyposis colorectal cancer 
HR   homologous recombination 
HRP   horseradish peroxidase 
IF   immunofluorescence 
IgG   immunoglobulin G 
IP   immunoprecipitation 
IPTG   isopropyl β-D-1-thiogalactopyranoside 
IR   ionizing radiation 
JNK   Jun N-terminal kinase 
Kan   kanamycin 
kb   kilo-base pair 
KD   kinase domain 
kDa   kilo Dalton 
LB-medium  Lysogeny broth medium 
LTR   long terminal repeats 
MBP   myelin basic protein 
Mec1   meiosis entry checkpoint 1 
MCF7   human mammary adenocarcinoma cells 
MDC1   Mediator of DNA-damage Checkpoint 1 
MECP2  methyl CpG binding protein 2 
MEF   mouse embryonicf 
mg   milligramm 
min   minute(s) 
MMR   mismatch repair 
Mre11   meiotic recombination 11 homolog 
MRN   Mre11-Rad50-Nbs1 complex 
mRNA   messenger RNA 
MutH   mutator H 
MutL   mutator L 
MutS   mutator S 
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NBS1   Nijmegen breakage syndrome 1 
NCBI   center for biotechnology information 
ng   nanogramm 
NHEJ   non-homologous end joining 
NER   nucleotide excision repair 
NES   nuclear export signal 
NLS   nuclear localization signal 
N-terminus  amino-terminus  
o/n   over night 
p53   protein 53 
p53Ser15  p53 phosphorylated at serine 15 
p53Ser46  p53 phosphorylated at serine 46 
p21   protein 21 or cyclin-dependent kinase inhibitor 1 
PAGE   polyacrylamide gel electrophoresis 
PARP1   poly ADP ribose polymerase 1 
Pax6   paired box 6 
PBS   phosphate buffered saline 
PcG   polycomb group  
PCNA   proliferating cell nuclear antigen 
PCR   polymerase chain reaction 
PFA   paraformaldehyde 
pM   picomolar 
PML   promyelocytic leukemia 
PMSF   phenylmethylsulfonylfluorid 
pol   polymerase 
PRC2   polycomb repressor complex 2 
PVDF   polyvenylidene difluoride 
RdDM   RNA-directed DNA methylation 
Rev   reverse 
RNA   ribonucleic acid 
RNAi   RNA interference 
ROS   reactive oxygen species 
RPA   replication protein A 
rpm   rounds per minute 
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RT   Reverse Transkription 
s   second(s) 
Scc   sister chromatid cohesion  
SDS   sodium dodecylsulfate 
shRNA   small hairpin RNA 
Siah   Seven in absentia homolog  
SIP   Siah Interacting Protein 
siRNS   small interfering RNS 
SMC   structural maintenance of chromosomes 
SMUDO  SMC-hinge and MutL-homology domain 
SmcHD1  structural maintenance of chromosomes hinge domain containing 1 
SP/TP   serine-prolien/threonine-proline motif 
SQ/TQ   serine-glutamine/threonine-glutamine motif 
SRS   Speckle Retention Signal 
SSB   single-strand break 
SUMO   small ubiquitin-related modifier 
SUMOylation  modification by covalent SUMO binding 
T/T   thymine/thymine mismatch 
Tab.    Table 
TAE   tris/acetate/EDTA 
TBS   tris-buffered saline 
TCL   total cell lysate 
TDG   thymine DNA glycosylase 
TEMED  tetramethylethylendiamine 
TGFβ   transforming growth factor ß 
Tris   tri(hydroxymethyl)aminomethane 
U   unit  
U2OS   human osteosarcoma cells 
UDG   uracil DNA glycosylase 
UV   ultraviolet 
V   Volt 
vol/vol  volume/volume 
vol/wt   volume/weight 
VSV-g   vesicular stomatitis virus glycoprotein G 
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WB   Western blot 
WDTC   well-differentiated thyroid carcinoma 
WSB1   WD40 repeat/SOCS box protein 1 
WT   wild type 
ZBTB4   zinc finger and BTB domain containing 4 
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